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Executive Summary 
An interconnected network of accredited federal, state, local, tribal, and territorial laboratories 
is critical to ensuring the safety of the U.S. food supply and the development of the Integrated 
Food Safety System (IFSS). In 2004, as part of a national policy to defend the U.S. food supply 
against terrorist attacks, major disasters, and other emergencies, the Food Emergency 
Response Network (FERN) was created to integrate the nation’s multilevel (i.e., federal, state, 
local, tribal, territorial) food-testing laboratories to detect, identify, respond to, and recover 
from a bioterrorism act affecting the safety of the food supply, or a public health 
emergency/outbreak involving the food supply. Since 2004, federal agencies have invested an 
estimated $200 million in FERN. The majority of this investment has been in the FERN 
cooperative agreements with FDA and USDA-FSIS investing $95.8 million and $69 million, 
respectively. FDA has promoted the accreditation of state laboratories through cooperative 
agreement funding, investing more than $50 million to fund these grants. 
On November 11, 2014, the Office of Regulatory Affairs (ORA) requested that the FDA Science 
Board establish a subcommittee to evaluate current investments in: (1) the FERN cooperative 
agreement funding program (CAP), and (2) funding for state laboratories to achieve 
International Organization for Standardization (ISO) accreditation. The goal was to ascertain 
how ORA can advance and establish an effective integrated laboratory network among ORA, 
FDA Center, and state public health and food- and feed-testing laboratories. In response to this 
request, the Science Board created the ORA FERN Cooperative Agreement Evaluation 
Subcommittee on July 1, 2015. This report summarizes the results of the Subcommittee’s 
review. 
The Subcommittee found that FERN plays a critical role in establishing a national, integrated 
food safety system and has had a significant public health impact. FERN is instrumental in 
increasing national capability and capacity to detect, prevent, prepare for, respond to, and 
recover from threats to our country’s food supply. FERN has successfully promoted integration 
of regulatory functions and emergency response preparedness in laboratories across the 
nation; however, with nearly 170 laboratories among the FDA, CDC, USDA-FSIS, and states, 
there are many more laboratories than FDA and USDA-FSIS have funds to support. Therefore, it 
is important for FDA (and consequently USDA-FSIS) to critically evaluate how FERN’s limited 
funds can best be utilized to build a sustainable integrated laboratory network that meets 
public health and regulatory needs within an integrated national food safety system. 
FDA’s commitment to provide future funding opportunities to FERN will be required to sustain 
and ensure the realization of a fully integrated multilevel (e.g., federal, state, local) food-testing 
laboratory network. Such future funding increases should be to increase the depth and breadth 
of the program, meaning both further increases to the capacity of existing laboratories as well 
as expanding the numbers of laboratories receiving FERN support. Further, it is important that 
FDA modernize its food safety information architecture to ensure safe and secure transmission 
of data even while encouraging and facilitating efficient data sharing and collaboration across 
the entire network of food safety regulatory laboratories. Investments in FERN should save 
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money in terms of reduced public health costs as well as costs to industry, but metrics are 
needed to more directly assess public health impacts, functionality of the network as a system, 
as well as other goals, such as efficiency. Importantly, FDA has the opportunity, in collaboration 
with USDA-FSIS, to continue to develop and expand the FERN network. Specifically, the 
Subcommittee makes the following recommendations: 
1. FERN consists of a group of diverse laboratories, and the focus on developing a basic level 
of capability/capacity across the network is a worthwhile goal that should be supported by 
the federal government. The baseline capabilities/capacities needed are not static and 
funding should be adapted to reflect these changing needs. 
2. Efforts to build and sustain capabilities/capacities across FERN need consistent, multi-year 
funding. FDA should consider additional sources of funding, including cost-sharing or 
matching requirements for grant programs and recipients, where appropriate and/or 
possible. 
3. While all laboratories should strive to improve capabilities, especially as some techniques 
become more routine, FDA should develop a plan for FERN that would consider the 
advantages of a tiered approach designed to avoid unnecessary duplication, for example, of 
expensive instrumentation across the network. Thus, while all laboratories should share a 
basic level of functionality, the advanced performance capabilities could be housed 
primarily or exclusively in regional/national facilities and/or centers to promote efficient 
use of existing expertise, equipment, and technical resources. 
4. FERN funding agencies (i.e., FDA/ORA, USDA-FSIS) should continue to improve their 
engagement with the CDC/LPRB-LRN Program Office to discuss areas of common interest 
and combine efforts to improve testing capacity and capability within and across networks. 
5. FDA should develop a technology-management plan to anticipate the eventual replacement 
of existing instrument platforms that employ newer and more advanced diagnostic 
methodologies. The plan should be developed in collaboration with the Centers of 
Excellence and include: platform selection, acquisition, upgrades/enhancements, along with 
corresponding technical training for personnel. 
6. FDA should assume a holistic approach to addressing the IT and data-sharing needs of FERN 
partners. There is a strong public health need for an integrated information infrastructure 
that allows the seamless transmission of data in a secure environment that facilitates rapid 
analytics. Simply trying to fix the current system is unlikely to achieve this goal; a new 
system is needed. Such efforts must be guided by a comprehensive plan that is developed 
through stakeholder engagement (i.e., cooperative agreement laboratories) to meet the 
needs of an integrated food and feed safety system. 
7. FERN leadership should develop clear objectives and adopt a set of metrics for both 
individual laboratories and the network, with appropriate targets and consensus as to what 
constitutes success and reflects the objectives. 
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8. FDA, in collaboration with other federal agencies, should convene an annual conference for 
the food safety laboratory network to engage scientists in professional 
education/development activities and facilitate the sharing of information. 
9. FERN should have the capacity to support professional travel to conferences and/or for 
training and development. 
10. FDA and its sister federal agencies (i.e., USDA-FSIS, CDC) should work with states on best 
practices for hiring and retaining scientists who are needed to perform this mission-critical 
work. Possible collaborators for initiating such efforts include the National Governor’s 
Association and/or National Conference on State Legislatures. These organizations may be 
able to assist with the identification and/or development of models that can be considered 
for adoption by states nationally. 
11. FDA should regularly communicate with all eligible laboratories to increase public health 
preparedness and participation in FERN training efforts. 
The Subcommittee advises that the recommendations of this report be accepted with the 
utmost urgency and that our specific recommendations be considered as a means of ensuring 
the maintenance of a safe and secure food system. The FERN network represents one of the 
best national investments in improving the responsiveness of our combined federal, state, local 
and territorial governments; the development of IFSS; and the prevention of foodborne 
disease. 
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1. Introduction 
Foodborne diseases are a significant public health issue in the United States, causing an 
estimated 48 million illnesses, 125,000 hospitalizations, and 3,000 deaths annually, according to 
the Centers for Disease Control (CDC).1,2,3 The U.S. food system is complex, and managing risks 
throughout the supply chain is a challenging task that requires an integrated, risk-based 
approach. Recognizing this, Congress enacted the Food Safety Modernization Act (FSMA) in 
January 2011, providing the first major overhaul of food safety oversight at the U.S. Food and 
Drug Administration (FDA), which oversees the safety of approximately 80% of the food supply, 
in nearly 70 years.4 
FSMA directs FDA to build, in partnership with other federal, state, local, tribal, and territorial 
food safety agencies, an Integrated Food Safety System (IFSS) that is focused on prevention and 
enhanced collaboration across these safety agencies.5 Specifically, FSMA directs FDA to develop 
and implement strategies to leverage and enhance food safety and defense capacities of state 
and local agencies, including establishing a program for the testing of food by accredited 
laboratories6 and the Integrated Consortium of Laboratory Networks (ICLN).7 
An interconnected network of high-quality federal, state, local, tribal, and territorial 
laboratories is critical to ensuring the safety of the food supply and the development of IFSS. In 
2004, as part of a national policy to defend the food supply against terrorist attacks, major 
disasters, and other emergencies, Homeland Security Presidential Directive 9 (HSPD-9) required 
the development of nationwide laboratory networks for food, veterinary, plant health, and 
water quality (e.g., FERN, Vet-LIRN, NAHLN, EPA) that: (1) integrate existing federal- and state-
government laboratory resources, (2) are interconnected, and (3) utilize standardized 
diagnostic protocols and procedures.8 
In response to HSPD-9, the Food Emergency Response Network (FERN) was created to integrate 
the nation’s multilevel (i.e., federal, state, local, tribal, territorial) food-testing laboratories to 
detect, identify, respond to, and recover from a bioterrorism act or public health 
emergency/outbreak involving the food supply. FERN has four main objectives: 
1) Prevent attacks on the nation’s food supply by providing means for early detection of 
threat agents; 
2) Prepare member laboratories (i.e., federal, state, local, tribal, territorial) to respond to 
food-related emergencies; 
                                                          
1 http://www.cdc.gov/foodborneburden/2011-foodborne-estimates.html 
2 Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, et al. 2011 (Jan.). Foodborne Illness Acquired in the 
United States—Major Pathogens. Emerging Infectious Diseases, 17(1):7–15. 
3 Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. Foodborne Illness Acquired in the United States—Unspecified Agents. 
Emerging Infectious Diseases, 17(1):16–22. 
4 http://www.fda.gov/Food/GuidanceRegulation/FSMA/default.htm 
5 FSMA Act – Section 209 
6 FSMA Act – Section 202 
7 FSMA Act – Section 203 
8 Homeland Security Presidential Directive/HSPD-9. 2004 (Jan. 30), http://fas.org/irp/offdocs/nspd/hspd-9.html 
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3) Provide and coordinate regional and national surge capacity for laboratories; 
4) Assist in recovery efforts to restore confidence in the food supply following a threat or 
actual emergency. 
FERN, which is coordinated by the U.S. Food and Drug Administration (FDA) and the U.S. 
Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS), provides multiple 
areas of support to member laboratories, including cooperative agreement funding. Currently, 
there are 170 member laboratories in FERN, and through cooperative agreements, FDA funds 
33 state laboratories; the latter include 13 chemistry laboratories, 15 microbiology laboratories, 
and 5 radiology laboratories. These laboratories are intended to provide increased capability 
and capacity for conducting sample analyses of food products for the rapid detection and 
identification of large-scale food contaminations, intentional or accidental, and have provided 
these functions for the FDA in most of the large-scale national food events since their initial 
funding. According to FDA, approximately $95.8 million has been awarded to state, local, tribal, 
and territorial laboratories since 2005, and an estimated $500,000 is spent internally each year 
to support FERN activities. 
On November 11, 2014, the Office of Regulatory Affairs (ORA) requested that the FDA Science 
Board establish a new subcommittee to evaluate the current investments in: (1) the FERN 
cooperative agreement program, and (2) funding for state laboratories to achieve International 
Organization for Standardization (ISO) accreditation.9 The goal was to ascertain how ORA can 
advance and establish an effective integrated laboratory network among ORA, FDA Centers, 
and state public-health and food- and feed-testing laboratories. In response to this request, the 
ORA FERN Cooperative Agreement Evaluation Subcommittee of the Science Board to the Food 
and Drug Administration (Subcommittee) was established on July 1, 2015 (Appendix A). 
2. Charge to the FERN Cooperative Agreement Evaluation Subcommittee 
The scope of work for this Subcommittee includes evaluation of three existing FDA state 
cooperative agreement program (CAP) grants to enhance FERN laboratory capability/capacity, 
help laboratories attain accreditation, and integrate the food safety community, and to assess 
how these agreements or other approaches can best be utilized to build an integrated 
laboratory network among public health and food- and feed-testing laboratories. 
Specifically, the question to the Subcommittee is how can the Agency continue to build a 
sustainable, integrated, and mutually reliant laboratory network that meets the public health 
and regulatory needs under an integrated national food safety system? Integrated refers to the 
combining of both regulatory and emergency response functions within each laboratory, and 
mutually reliant refers to the capacity and capability of laboratories — be they state, CDC, FDA, 
                                                          
9 
http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/ScienceBoardtotheFoodandDrugAdministration/ucm4
23187.htm 
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USDA-FSIS, or food- and feed-testing laboratories — to be able to rely on each other to provide 
testing and regulatory data and analyses that are reliable in their respective functions. 
The Subcommittee’s scope of work also includes an assessment of the technical areas of data 
quality and sharing, proficiency testing, method harmonization, and analytical results reporting 
sufficient to allow recommendations that could facilitate the rapid and efficient interchange of 
laboratory results in an integrated laboratory network. 
Questions from ORA for the Board’s FERN Subcommittee to Address: 
1) How can we further promote and build an integrated laboratory network among the 
food regulatory laboratories of ORA, FDA Centers, USDA’s FSIS, and state health 
departments as part of developing a stronger system of mutual reliance in the food and 
feed program? 
2) What are the appropriate scientific, analytical and technical capabilities required to 
facilitate the sharing of laboratory data between public health and regulatory agencies 
in a timely and efficient manner to enhance consumer protection? 
3) What are the realized benefits and limitations to these FERN Network, laboratory 
accreditation, and Laboratory Associations (e.g., APHL, AFDO, AAFCO) cooperative 
agreements, and how can we improve upon the current utilization of the results of 
these agreements? 
4) How impactful to public health has this building of an integrated laboratory network and 
promotion of our state laboratories been to date? Explore case studies. 
5) What would be appropriate metrics to measure the effectiveness of these integration 
strategies in promoting a national integrated laboratory system? 
3. Evaluation Process 
The evaluation process used by the FERN Subcommittee consisted of a review of background 
materials; meetings and discussions with FDA, staff from state and local laboratories, and 
others; and a site visit. The Subcommittee met regularly via conference call to review 
documents and conduct interviews. 
The Subcommittee was provided with background documentation on FERN by the FDA-ORA 
Office of Partnership and the FERN National Program Office. The Subcommittee was provided 
with the latest available progress reports covering the performance dates from September 1, 
2015, through February 29, 2016, from 24 randomly selected laboratories provided by the FDA. 
Ten reports represented FERN/CAP-funded laboratories; another ten reports represented the 
ISO/IEC laboratories; while five reports represented ISO/IEC self-assessment gap-analysis. 
Budget plans from five state public health or agriculture laboratories that were awarded funds 
for both chemical and microbiology preparedness areas were evaluated for consistency of 
expenditures relative to expected outcomes. Additionally, the Subcommittee reviewed an 
interim progress report, dated March 30, 2016, from the Association of Public Health 
Laboratories (APHL) for a cooperative agreement for “Building an Integrated Laboratory System 
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to Advance the Safety of Food and Animal Feed.” Finally, the Subcommittee reviewed detailed 
budget information from FY15. 
The Subcommittee also invited FERN-relevant presentations by FDA and other organizations 
and conducted several interviews with management and leadership staff at laboratories in five 
non-funded states, including Florida, Indiana, New York, Pennsylvania, and Utah during 
separate teleconferences in February and March 2016. Presenters and interviewees, along with 
their institutional affiliations, are listed in Appendix B; questions drafted by the Committee are 
provided in Appendix C. 
To further inform its review with real-world data and information, the Subcommittee 
conducted a site visit in Richmond, Virginia, at the Division of Consolidated Laboratory Services 
(DCLS) on January 12, 2016. This FDA CAP laboratory was chosen for a site visit in part because 
it is generally regarded as a well-functioning, full-service laboratory, exemplary by virtue of its 
efficient, integrated, collaborative, and productive operations that are highly valued by FERN. 
The Richmond laboratory serves as a prime example of how federal resources could be, for 
example, leveraged in order to inform and train personnel from other facilities, tapped as a 
source of best practices, and modeled by other laboratories. Also, the Richmond laboratory is 
funded through cooperative agreements by both FDA and USDA-FSIS for chemical and 
microbiological analyses. In addition, USDA-FSIS, through its CAP, supports DCLS as a training 
center for other FERN laboratories. 
To produce the present report, the Subcommittee chair assigned individual Subcommittee 
members to compose first drafts of various chapters (i.e., Funding, Metrics, Data Analytics, 
Training and Development, and Impact on Public Health). The chair consolidated the drafts and 
compiled the final report with the assistance of a technical writer-editor. 
4. Overview of FERN 
FERN’s mission is to integrate the nation’s food testing laboratories at the federal, state, and 
local and tribal levels into a network that is able to respond to emergencies involving biological, 
chemical, or radiological contamination of food. FERN’s objectives are to provide for an early 
means of detecting threat agents in the U.S. food supply; prepare the nation’s laboratories to 
be capable of responding to food-related emergency events; provide surge capacity that will 
allow the nation to respond to food emergency events; and enhance the ability of the country 
to restore confidence in the food supply after an emergency or in response to a threat. FERN 
achieves its objectives by conducting laboratory testing and targeted surveillance programs; 
developing standardized food testing methodologies; providing chemical, microbiological, and 
radiological training activities; conducting proficiency testing; and facilitating communication 
among member laboratories. 
Federal, state, local, tribal, and territorial government food-testing laboratories that have 
chemical, biological, and/or radiological analytical capabilities can apply to become a member 
of FERN. As stated previously, there are currently 170 member laboratories in FERN, including 
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public health, agriculture, environmental, and veterinary diagnostic laboratories. Individual 
laboratories are categorized based on laboratory capability responses posted on the FERN 
website Laboratory Directory (LabDIR). Each laboratory has separate tabulations for each 
discipline registered, as well as one overall number obtained by totaling all of the disciplines 
registered for in LabDIR, and this is combined with the responses to the general laboratory 
questions for an overall result. Each laboratory’s total discipline-specific and overall scores 
determine the laboratory’s category. This tiering process facilitates the laboratory selection 
process for a FERN activation event. The categorization serves as a tool for FERN to view the 
capabilities of its member laboratories in real time and can be used as any other tool in the 
National Program Office/Regional Coordination Center tool belt, but is not an official 
requirement in the process of “activation” of FERN in responding to an emergency event. The 
individual assessment of laboratory capability/capacity in the FERN regions is done by the 
regional coordinators, in coordination with the National Program Office, in response to specific 
emergency events as part of the official “activation” of FERN. Several federal agencies are FERN 
partners, including FDA, USDA-FSIS, CDC, DOD, FBI, EPA, DHS, and DOE.10 The organizational 
structure of FERN is shown in Figure 1. 
Figure 1. FERN Organizational Structure. From: Biennial Report to Congress on the Food Emergency Response 
Network. 2013 (Nov.). Food and Drug Administration. 
Funds have been invested in FERN by both FDA and USDA-FSIS to enhance laboratory 
capacity/capability and by FDA to assist state laboratories in attaining laboratory accreditation 
                                                          
10 Frequently used abbreviations and acronyms are defined in the Abbreviations and Acronyms section at the beginning of this 
report. 
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in accordance with ISO International Electrotechnical Commission (i.e., ISO/IEC 17025:2005). 
ISO is an independent, non-governmental organization made up of members from the national 
standards bodies of 162 countries (http://www.iso.org). Accreditation by ISO is seen by many as 
a gold standard for establishing national laboratory standards and implementing a fully 
integrated national food safety system with mutually acceptable analytical data. Forty-six state 
FERN laboratories are currently being funded by the ISO/IEC 17025:2005 Cooperative 
Agreement. In 2015, findings of the food samples by these FDA/FERN-ISO-supported 
laboratories triggered two nationwide recalls of ice cream products for L. monocytogenes 
contamination. 
In addition, in 2014–2015, 15 FERN Microbiology Cooperative Agreement Program (MCAP) 
laboratories, many also funded to obtain laboratory accreditation through the ISO CAP, 
participated in FDA’s large-volume surveillance assignment, analyzing imported and domestic 
avocados for the presence of Salmonella and L. monocytogenes. Their sample results were used 
to establish statistically relevant risk assessments as well as to support FDA regulatory 
decisions. 
Selected state laboratories that are also members of FERN are the primary servicing laboratory 
for their respective state’s regulatory agency that is enrolled in the FDA’s Manufactured Food 
Regulatory Program Standards (MFRPS) and/or Animal Feed Regulatory Program Standards 
(AFRPS). These two sets of standards are used by the states to guide continuous improvement 
in food manufacturing and animal feed programs. Standard #10 of the MFRPS and AFRPS 
addresses state laboratory services and their quality management systems. Many of the states 
with FERN-supported laboratories that seek to attain laboratory accreditation participate in the 
FDA’s Rapid Response Teams, a program created to address the need for improved, integrated, 
and rapid responses to food- and feed-related emergencies. 
A cooperative agreement with the Association of Public Health Laboratories (APHL), the 
Association of Food and Drug Officials (AFDO), and the Association of Animal Feed Control 
Officials (AAFCO) has also been established to further regulatory laboratory integration. This 
agreement seeks to facilitate long-term improvements in the national food and animal-feed 
safety system by strengthening multi-disciplinary laboratory collaboration and equivalency, 
thereby advancing laboratory accreditation, and building an integrated community of federal, 
state, local, and tribal regulatory laboratories. 
5. General Findings 
This section summarizes the results of the Subcommittee’s review of: (1) the FERN CAP, and (2) 
funding for state laboratories to achieve ISO accreditation. The review includes an assessment 
of Public Health Impact (Section 5.1 below), Funding Mechanisms (Section 5.2), and Metrics 
(Section 5.3). The report also addresses two areas where the Subcommittee felt that 
improvements would increase the effectiveness of FERN: Data Analytics (Section 5.4) and 
Training and Workforce Development (Section 5.5). 
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5.1 Public Health Impact 
FERN plays a critical role in establishing a national integrated food safety system by increasing 
national capability and capacity to detect, prevent, prepare for, respond to, and recover from 
threats to the country’s food supply. Because the FERN CAP laboratories bring training assets as 
well as provide equipment and personnel, they are able to rapidly respond to these threats to 
the food supply. They also provide FDA with increased capacity and capability in fulfilling its 
responsibility to respond to such threats. The following sampling of a range of significant 
national and international incidents highlight the critical value of the FERN laboratories in 
helping maintain a safe food and feed supply. 
FERN CAP laboratories were instrumentally important, for example, in the national response to 
the melamine adulteration incidents of 2007 and 2008 that affected the safety of the food and 
feed supply in China and elsewhere. In the pet-food adulteration incident of 2007, FERN 
chemistry laboratories worked with FDA laboratories to develop and validate a screening 
method to detect this toxic industrial compound in pet food. The FERN laboratories analyzed 
more than 200 samples as part of an FDA assignment to determine the extent of contamination 
of the nation’s pet-food supply. The subsequent melamine adulteration incident involving milk 
and infant formula products (2008–2009) spurred FERN laboratories to develop two new 
methodologies to detect melamine and melamine by-products in milk-containing foods. The 
FERN laboratories then analyzed more than 300 samples, providing additional analytical surge 
capacity to FDA field laboratories in protecting public health. 
In addition, following the 2010 Deepwater Horizon oil spill in the Gulf of Mexico, FERN CAP 
laboratories provided much-needed method development and analytical capacity that allowed 
a safe reopening of the Gulf waters to commercial fishing. FERN laboratories, along with an FDA 
laboratory, developed and validated a new rapid-screening method to detect petroleum 
contamination in seafood, decreasing by half the amount of time that previous analytical 
methods had required. The FERN laboratories were thus able to rapidly analyze more than 460 
samples, making possible more rapid access to the Gulf by the commercial fishing industry. 
In 2011, FERN radiological CAP laboratories were activated to respond to the Fukushima, Japan 
nuclear disaster. FERN laboratories, in collaboration with the FDA radiological specialty 
laboratory, participated in method development and validation; both federal and state sample 
testing laboratories used these FERN methods and its equipment for rapid and extensive testing 
of suspect products. These FERN accomplishments helped ease the public’s fear of possible 
radiological contamination. 
Finally, the FDA engaged FERN CAP laboratories to expand the testing capacity to detect arsenic 
in juices and rice products in 2012. FERN chemistry laboratories were activated to analyze 
backlogged samples, allowing a quicker determination of the extent of arsenic contamination in 
these products. 
An example of the integration of both the FERN cooperative agreement program and the ISO 
accreditation program would be the 2015 nationwide recalls of ice cream products due to L. 
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monocytogenes contamination. These recalls were triggered by the analytical work of 
FDA/FERN-ISO-supported laboratories, with the rapid analytical data acceptance facilitated by 
the laboratory quality systems being installed with the ISO cooperative agreement funding. 
 5.2 Funding Mechanisms 
The Subcommittee evaluated three existing funding agreements, which were funded in FY15 as 
follows: (1) FDA FERN Cooperative Agreement Continuation Program, U18 ($10.1M); (2) ISO/IEC 
17025:2005 Accreditation for State Food Testing Laboratories, U18 ($9.3M); and (3) Building an 
Integrated Laboratory System to Advance the Safety of Food and Animal Feed, U18, ($1.1M).11 
The FERN funding mechanism has existed since FY05, and the other two funding agreements 
have been in place since FY12,12 with year-to-year funding levels remaining relatively consistent 
over the last eight years (Figure 2).13 
The FERN Cooperative Agreement Program offers funding on a competitive basis to state, local, 
tribal, and territorial FERN laboratories to increase analytical capacity and expertise during 
events that require surge capacity testing of samples, including the provision of supplies, 
personnel, facility/equipment upgrades, training in current testing methodologies, participation 
in proficiency testing, participation in method enhancement activities and analysis of 
surveillance and emergency outbreak samples.14 In FY15, the FERN CAP provided a total of 
$10.1M to 26 awardees15, including 14 chemistry laboratories, 14 microbiology laboratories, 
                                                          
11 Indicative of the funding range, in prior years, this third CAP funding stream had been as high as $1.5M. 
12 In FY15, the three FERN funding streams were consolidated into one. 
13 In FY13, federal budget sequestration impacted these three programs, wherein #3 incurred a 50% cut, for example. While 
most programs’ funding was eventually restored, some FERN programs have not been restored to pre-sequestration levels. 
14 https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-019.html 
15 Some laboratories have more than one discipline. 
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and 5 radiology laboratories; the period of performance for each award was one year with the 
possibility of up to four additional years of funding, depending on performance and continued 
availability of federal funds. FDA funding for the FERN CAP has been relatively level (FY12 = 
$10.6M; FY13 = $9.5M; and FY14 = $10.1M) but has been limited to current FERN laboratories. 
The selection process for the cooperative agreements considered several criteria, including: (1) 
current capabilities and capacities of the laboratories; (2) abilities of laboratories to perform 
large-scale testing for FERN, if requested to do so; and (3) geographical distribution of selected 
laboratories across the nation.16 
The ISO/IEC 17025:2005 Accreditation for State Food Testing Laboratories Cooperative 
Agreement Program has a $9.3M annual appropriations limit and provides funds to 46 state 
food testing laboratories to obtain, maintain, and/or expand laboratory accreditation to 
recognized international standards (ISO/IEC 17025:2005). The goal of this ISO-related funding is 
to achieve a nationally integrated food safety system that can be further expanded. The 
agreement’s purpose is three-fold: (1) conduct food analyses in accordance with the 
procedures of an ISO/IEC 17025:2005-accredited laboratory, (2) maintain the accreditation of 
presently accredited laboratories and/or expand the scope of ISO to additional sections within 
the laboratory, and (3) achieve laboratory conformance with Standard #10 of the Manufactured 
Food Regulatory Program Standards (MFRPS). Standard #10 requires that all food testing 
performed for the program be done in regulatory laboratories that are accredited in 
accordance with ISO/IEC 17025:2005, or are implementing quality systems on par with ISO/IEC 
17025:2005. The intended outcome is for microbiological and chemical food analyses 
performed on behalf of state manufactured food regulatory programs to be conducted in 
compliance with the procedures in an ISO/IEC 17025:2005-accredited laboratory. 
The Building an Integrated Laboratory System to Advance the Safety of Food and Animal Feed 
Cooperative Agreement Program was established to strengthen multi-disciplinary laboratory 
collaboration and equivalency; establish a platform for building an integrated laboratory 
community; and advancing the sharing, equivalency and acceptability of laboratory results.17 
This CAP, which is limited to national non-profit organizations, guarantees support for one year, 
with the possibility of up to four additional years of funding, depending on performance and 
continued availability of federal funds. The CAP has an annual budget of $1.5M with a period of 
performance from September 2012 through August 2017; and, as of this writing (September 
2016), this is the fifth year in which APHL has received this award. APHL is required to sub-
award a minimum of 25% of the funds received to at least two different associations, one 
representing state manufactured food regulatory officials (e.g., Association of Food and Drug 
Officials [AFDO]) and the other association must represent state animal feed regulatory officials 
(e.g., Association of Animal Feed Control Officials [AAFCO]). 
The Subcommittee reviewed the latest available progress reports covering the performance 
dates from September 1, 2015, through February 29, 2016, from 24 randomly selected 
                                                          
16 The FY15 FERN RFA restricted eligibility to only those laboratories that were receiving funding at the time of application. 
17 http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-025.html 
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laboratories provided by the FDA/ORA FERN Program Office. Ten reports represented FERN-
CAP-funded laboratories; another ten reports represented the ISO/IEC laboratories; while five 
reports represented ISO/IEC self-assessment gap-analysis. Budget plans from five state-level 
public health or agriculture laboratories that were awarded funds for both chemical and 
microbiology preparedness areas were evaluated for consistency of expenditures relative to 
expected outcomes. An effort was also made to determine each of the laboratories’ pre-
funding status prior to September 1, 2015, to evaluate the effectiveness of the program’s ability 
to achieve the targeted outcomes. Finally, the Subcommittee reviewed APHL’s March 30, 2016, 
interim CAP progress report for Building an Integrated Laboratory System to Advance the Safety 
of Food and Animal Feed. 
From the review of the progress reports, we made a number of findings.18 Generally, FERN’s 
existence expands the FDA’s laboratory-based regulatory capacity as the network 
simultaneously serves in the promotion of emergency-related food safety through the sharing 
of regulatory data. FERN acts as an additional resource, enhancing FDA’s existing capacity. 
Meaningful progress has been made in performance areas such as sample analysis or 
surveillance events; method extension or enhancement studies and proficiency testing (PT) 
challenges. All the grantees were involved in increased sample analysis or threat-related 
surveillance testing; the number of events ranged from one to nine, with an average of four 
events per laboratory. Of special note, expenditures for acquiring necessary scientific expertise 
comprised the largest budget line item, with the combined chemistry and microbiology 
personnel expenses (approximately $144,000/FTE), totalling 50% of the grant, and ranging from 
22 to 86% of the total annual award per grantee. On average, grantees reported six FDA-
purchased and/or loaned equipment/instrumentation acquisitions, directly enhancing the 
network’s overall testing capability and capacity. Nine of the reviewed grantees completed 19 
method extension/enhancement studies. Furthermore, all laboratories completed two PT 
challenges between September 1, 2015, through February 29, 2016, and some completed as 
many as four. Historically, since 2004, the FERN PT program has administered 63 separate PT 
exercises involving microbiology, chemistry, and radiochemistry. 
An FY15 budget review from a cross-section of five (~20%) of the 26 participating state 
laboratories revealed funds were used in an efficient manner, supporting expenditures and 
activities that contribute to expected outcomes. Pre-assessment gap analyses indicate that 
laboratories that were selected to receive funds for ISO/IEC 17025:2005 had well-designed and 
high-quality management infrastructure with an enhanced likelihood to achieve ISO/IEC 17025 
accreditation. Reports reviewed by the Subcommittee from 19 laboratories revealed that six 
were ISO/IEC 17025:2005 accredited, four had completed and submitted their 17025 
application, and the remaining nine were on schedule with their respective accreditation action 
plan. At present, 18 of 36 awardees (50%) are ISO/IEC 17025:2005 accredited. 
                                                          
18 Unfortunately, APHL’s year-four report was not organized in a standardized manner that would allow the Subcommittee to 
report progress across the nine activity areas as defined in the Funding Opportunity Announcement. 
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 5.3 Metrics 
Since its inception, FERN has established and maintained cooperative agreements with state, 
local, and tribal public health or agriculture laboratories. The cooperative agreements require 
that each funded/grantee laboratory meet criteria regarding staff training, analysts’ 
proficiencies, method development, testing-sample processing time (i.e., from the time that a 
sample is received to the time that testing results are reported), and dissemination of test 
results, where possible,  across the national network. Continuation of funding, which is 
renewable annually for up to five years, is contingent upon the laboratory fulfilling the 
expectations set forth in the cooperative agreement. 
At the FERN national program level, FDA and USDA-FSIS jointly determine the aggregate need 
for capability and capacity to respond to food-related emergencies. Capability (the ability to 
accurately perform the laboratory testing set forth in the cooperative agreement) and capacity 
(the ability to conduct the number of tests agreed to in the cooperative agreement and in the 
time specified) are periodically assessed through exercises. FDA and USDA-FSIS have developed 
metrics at the agency level and the national-program level (Appendix D), not all of which have 
been included in the cooperative agreements or tracked at an enterprise level. 
The Laboratory Response Network (LRN), managed by the CDC, has an analogous mission to 
that of the FERN and responds to public health emergencies, especially those involving selected 
agents. The Subcommittee agreed that many of the metrics used currently by the LRN could 
readily be adapted for use by the FERN. The LRN capability assessment is focused on five 
functions: 
1) Managing laboratory activities, 
2) Performing sample management, 
3) Conducting testing and analysis for routine and surge capacity, 
4) Supporting public health investigations, and 
5) Reporting results. 
Each function consists of specific tasks, which are assessed by one or more distinct 
performance measures. The Association of Public Health Laboratories (APHL) has also 
developed an extensive set of metrics for cooperative agreements (Appendix D), some of which 
could be adapted by the FDA and FERN. 
 5.4 Data Analytics 
Access to high-quality data collected throughout the food system, as well as the ability to 
conduct meaningful statistical analyses on such data, is critically important to implementing an 
integrated food safety system. Data analytic tools and infrastructure — including computational 
capacity, data storage, and communications capabilities that allow efficient data acquisition, 
retrieval, and sharing among laboratories — as well as up-to-date statistical software and staff 
competencies, all contribute to timely and efficient utilization of data for risk-based decision-
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making. Given the objectives of FERN, it is essential that the network’s data analytics19 
functions are working well and seamlessly across all partnering institutions. 
The FERN Subcommittee reviewed multiple reports, conducted site visits, and interviewed a 
number of collaborative laboratories. Findings include the fact that, today, FERN laboratories 
generate data and attempt to transfer data to FDA by email and fax, after which it is generally 
re-entered manually into statistical software such as spreadsheets and analysis software. The 
Subcommittee believes that the archaic transfer mechanisms and the manual re-entry of data 
poses a major risk to data integrity, and is a stumbling block to willingness/ability to share. 
Among the many issues that apparently drive this situation is an IT firewall/cybersecurity 
concern that is designed to reduce risk of access to FDA data systems and thereby isolate them 
from their partners in the FERN network. Because the FDA must use data to serve its regulatory 
mission, functions, and actions, the security and integrity of that data is paramount. 
Nevertheless, if the basic security concerns preclude a desire and willingness of fully vetted 
partners to contribute, it in essence has the ability to cripple the intent of the network. 
FDA’s security/integrity concerns, relative to its FERN partners, compromise the adequacy of 
data sharing and thus the capacity of the entire system to function efficiently and effectively. 
Attempts have been made to develop alternate approaches such as using an FDA-owned 
computer located at the partnering association for the data transfer. However, these attempts 
have also failed to find a functional process. This matter deserves a high-level policy discussion 
and consideration as to how the FDA’s IT system can be changed to also advance the success of 
an integrated national foodborne illness prevention and mitigation program. In the end, the 
only solution may be to develop a new modern IT infrastructure, built from the ground up with 
both adequate security as well as ease of access and use in mind. 
Currently, regulatory inspection data also are manually entered into FDA computers from the 
FERN network. Double entry results in significant errors and lost time. Implementation of a very 
basic file transfer capability, as an interim measure, should be explored to address these 
manual entry data risks. The Subcommittee recognizes that a balance must be achieved that 
serves data security needs and also preserves some degree of access that is dramatically 
improved from the status quo and thus serves the public health needs for mitigating food-
related illness. Decision making by FDA must be evidence based, and the FERN network should 
be recognized as an important part of the foundational knowledge base. 
The Subcommittee came to realize through its interviews and observations that the 
independence of state laboratories may exacerbate the data-sharing problem; however, this 
should be mitigated once a modern IT-infrastructure — delivering security and accessibility — is 
incorporated into the FDA system. When FERN is establishing various events for collaboration, 
there is a clearly perceived value and appreciation on both the state and FDA laboratory side. 
That goodwill is visibly eroded by relegating key data unusable when placing it behind partner-
                                                          
19 For the purposes of this report, the Subcommittee defines data analytics as the combined capabilities that facilitate accessing 
and sharing relevant data within FERN and completing appropriate computations on the data in a quick and efficient manner. 
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inaccessible firewalls. 
The eLEXNET presents a theoretical design possibility by allowing a dual construction (i.e., 
having both a firewall-protected FERN functionality and a non-firewall-protected food data 
analytics sharing component), and this approach might make sense for FDA. However, the lack 
of functionality on the non-firewall side defeats the purpose and may again discourage the use 
of eLEXNET. In addition, because eLEXNET is a fairly old IT system, the question arises as to 
whether it is more efficient to support the current system or redesign with a modern IT 
infrastructure that equally addresses security and access. This may sound simplistic, but 
weighing the lessons learned and the newer approaches in database design may point to 
greater value in the long-term gains to be realized from redesigning and building anew. 
The Subcommittee also considered the IT needs of FSMA and determined that there is a 
concern that FSMA needs may be decreasing much-needed attention to FERN. This is yet 
another impediment to addressing the complicated FERN resource issues. Regardless of the 
competing interests between different FDA functions, managing legacy data is not trivial and 
must be taken into account when the IT system is redesigned to achieve serious gains in 
functionality. In conclusion, the task of migrating legacy data must be incorporated from the 
outset in the planning of any future effort. 
Thus, moving data into the FDA/USDA-FSIS system is a technical problem that imposes a burden 
on staff time and compromises database quality control. At the center of this challenge is 
eLEXNET, an outdated data management system that is currently undergoing updating and 
improvements and that is not protected by a cyber-secure firewall. Many laboratory staff, 
consequently, do not see a benefit in using this system, largely because, unlike staff of the state 
department of health or other relevant state agency, they do not generally need to access this 
data that is collected from across the states. Some IT effort, such as the Partnership for Food 
Protection (PFP) Information Technology (IT) workgroup, is now being devoted to ameliorate 
this barrier to a more seamless transmission of data from the state level into the fire-wall-
protected FDA/USDA-FSIS system. It seems clear that any solutions to this data migration 
matter will be more successful if their design is driven by the information needs of the users. 
 5.5 Training and Workforce Development 
Optimal response to food emergencies requires that several disparate types of technical, 
material, and human resources be in place at all times, and it requires that effective protocols 
be established, understood, and carefully followed. For example, laboratories require: (1) 
trained and expert staff who have appropriate levels of relevant educational background; (2) 
staff access to continuous training and educational opportunities in order to maintain and 
increase skills and knowledge; (3) up-to-date equipment and facilities to be able to assist with 
analyses and seamlessly and efficiently share data and information within the network, (4) 
adequate communication capacity in order to engage other networked laboratories and to 
share data and information, as needed; and (5) funding to respond to emergencies as they 
arise. 
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FERN has a strong focus on training and workforce development among the network of 
laboratories that it supports and with which it collaborates. Specifically, training is offered in a 
number of areas that have relevance to responding to bioterrorism and infectious disease 
outbreaks: detection of radiological, chemical, and microbial agents; detection of select-agents 
(e.g., toxins/poisons, disease-causing viruses and bacteria); and rapid-detection methodologies. 
The FERN network also has helped develop and promote the use of more up-to-date 
technologies for laboratory analyses. This, in turn, results in increasing the capacity of the 
workforce in FERN-affiliated laboratories. The network engages its members in laboratory 
proficiency testing exercises — as well as quality assurance and auditing training — that help 
improve practices across a range of functions and responsibilities of the FERN system. 
These activities have supported not only training and development of the existing laboratory 
workforce but also the ability to recruit new scientists who are more attracted to working in a 
laboratory environment that is more state-of-the-art and operational. Moreover, because the 
FERN network makes available electronic communication and collaboration tools, these assets 
have the potential to assist personnel across collaborating laboratories in learning how to 
utilize and adopt new practices that increase efficiency and accuracy of laboratory functions. 
The Subcommittee believes the value of the FERN network for enhancing training is apparent. 
The Richmond, Va., laboratory is funded by the USDA-FSIS to serve as a training center for other 
laboratories. The Subcommittee visited the Richmond laboratory, which has developed a well-
equipped training facility. The Subcommittee learned of several anecdotal examples of state 
laboratory scientists who had participated in FERN network training then becoming the de facto 
subject-matter experts on those issues within their own states. 
The Subcommittee believes that the FERN-enabled training is a valuable way for the federal 
government to leverage the personnel in the FERN network to share best practices and to train 
personnel across the FERN system. However, while some training efforts are broadly available, 
other training efforts only benefit laboratories that are part of the FERN network. Another issue 
that needs to be addressed is travel for training. State laboratory representatives with whom 
the Subcommittee spoke indicated that most of their staff travel is funded by grants and that 
even when there are grants, there are several levels of approval that can create obstacles to 
staff access to training. States need both access and funding to participate in training or more 
training solutions such as the Richmond laboratory’s creative “training in-the-box” system that 
does not require travel. 
In terms of workforce development, there are several ways that the FERN network is effective, 
and could be more effective. The very process of engaging the FERN network laboratories in 
development and deployment of new laboratory technologies, as well as in efforts to boost 
staff proficiency in applying laboratory methods and adopting new electronic systems, 
indirectly helps to support the professional development of the laboratories’ workforce. 
However, the program seems to have reduced the frequency of conferences and other venues 
that help to build professional networks that in turn promote continuing development of the 
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scientists in the FERN laboratories. Also the ability to attend professional conferences helps 
enable the recruitment and retention of the best scientists. 
In addition, the Subcommittee learned of a number of obstacles caused by states’ personnel 
processes that were adversely impacting the network’s national capacity to be effective. Some 
of these problems include: the inability to offer competitive salaries, excessive staff turnover, 
and lack of career mobility for scientists within some state personnel systems. These problems 
are not easy to address, but they are solvable. 
Specifics concerning FERN’s workforce-related challenges include the fact that salaries are not 
sufficiently competitive. Evidence of this relates to staff retention. For example, state 
laboratory staff have turned over four times in 12 years. To address this handicap, states would 
need to update personnel classifications. To the extent that FDA’s recent efforts to evaluate 
salary grades of ORA field staff might have an impact on FERN laboratory staff salaries is not 
known. 
Another workforce issue concerns professional development, for which there is a large need. 
This includes the need to increase opportunities for internships and fellowships. Perhaps FERN 
grants could be used to support attendance at conferences, enhance professional 
development, and create a learning environment that is attractive to scientists and 
characteristic of exchange of scientific discoveries and information (e.g., annual meetings of 
scientific societies). The current lack of funding for such has eliminated this important 
opportunity for competency development and education. Travel funds that promote 
professional development and networking are a part of this need and would contribute 
immensely to advancing this valuable component of developing and expanding our scientists’ 
professional networks. Training in the FERN laboratories, on the other hand, is an impressive 
counter to the limitations in professional development opportunities. For example, the training-
in-the-box approach allowed for regional lab staff to join remotely in training exercises where 
materials and reagents were shipped to remote locations and virtual training programs using 
voice and video connection allowed for remote hands on training. The Subcommittee was 
impressed with this creative approach to training. 
6. Conclusions 
The goal of this report is to ascertain how ORA can advance and establish an effective nationally 
integrated laboratory network among ORA, FDA Center laboratories, and state public health 
and food- and feed-testing laboratories. Specifically, the Subcommittee was asked to address 
five questions; below are the responses to these questions based on the Subcommittee’s 
review. 
6.1 Promoting and Building an Integrated Laboratory Network 
Question 1: How can we further promote and build an integrated laboratory network among the food 
regulatory laboratories of ORA, FDA Centers, USDA’s FSIS, and state health departments as part of 
developing a stronger system of mutual reliance in the food and feed program?  
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An evaluation of the current system including FERN indicates that efforts to date have laid the 
groundwork for a stronger, more integrated network of food regulatory laboratories that have 
a much greater scientific capacity and function in a more rapid and coordinated fashion in 
response to national food safety emergencies. At the same time, the Subcommittee concludes 
that there is a need to double down on the effort to strengthen the nation’s food regulatory 
laboratory system. The existing network could be made to operate much more effectively and 
efficiently if it were possible to overhaul systems for reporting and accessing data. As noted 
below, modern computer security systems should be able to embrace secure means of data 
transfer that allow for free exchange of data and analyses yet do not compromise computer 
systems within federal, state, and local governments. Second, the existing network could be 
leveraged to provide a higher level of training and technical support to all food regulatory 
laboratories in the nation, not just to those with FERN funding. Third, it is important to consider 
expanding the depth and breadth of FERN funding. Laboratories with FERN funding would 
benefit from additional resources for training and travel as well as more funding for large-
sample analytic demands. As noted below, the FDA and the public have benefitted from the 
investments in FERN to date. The FDA would benefit from the opportunity to expand the FERN 
network by being able to offer FERN grants to more state and local laboratories. 
Therefore, the Subcommittee concludes that the FDA has the opportunity to continue to 
develop and expand the FERN network. There is a wide range of capabilities and readiness to 
respond to food emergencies across FERN laboratories. However, with nearly 170 laboratories 
among the FDA, CDC, USDA-FSIS, and states, there are many more laboratories than FDA and 
FSIS have funds to support. Therefore, it is important for FDA (and consequently USDA-FSIS) to 
critically evaluate how FERN’s limited funds can best be utilized to build a sustainable 
integrated laboratory network that meets public health and regulatory needs within an 
integrated national food safety system. 
 6.2 Data Sharing 
Question 2: What are the appropriate scientific, analytical, and technical capabilities required to 
facilitate the sharing of laboratory data between public health and regulatory agencies in a 
timely and efficient manner to enhance consumer protection?  
The Subcommittee has identified a number of concerns regarding the lack of well-designed 
features as well as poor performance of the existing data-analytics infrastructure. 
First, the Subcommittee determined that FERN’s data analytical capability requires an efficient 
sharing of the range of data types among multiple network partners. Across FERN laboratories, 
the Subcommittee found an extraordinary dependence on the manual transfer of data from 
one platform or source to another — even to the point of staff having to resort to using faxes to 
share data between laboratories followed by a re-keying of data. This lack of seamless data 
transfer is a function of outdated and inadequate infrastructure resources and discrepancies in 
technology across laboratories. Needless to say, manual methods of sharing data are prone to 
significant errors and are highly inefficient. The Subcommittee discovered that this well-
 
 
20 
 
recognized weakness is often discussed in FERN laboratories and is rooted in fundamental 
differences among partners (i.e., CDC, FDA, USDA-FSIS, state laboratories) as to the need for, or 
the control of, data access. The fact that this is a long-term systemic problem has only 
exacerbated the issue and impacted staff morale and organizational commitment to the value 
of the FERN network. 
It appears that the regulatory function is driving the IT/supervisory reaction, causing the 
creation of an ultra-isolation model that does not have the flexibility to serve other important 
FDA functions. FDA should take advantage of other large data-sharing opportunities to create 
some unified data designs. Redesign of IT infrastructure should be done within the context of a 
long-range strategic planning process as well as within the context of delivering a rapid 
implementation of near-term fixes. As a redesign of basic system architecture is being 
implemented, IT considerations should focus early on avoiding a design dominated by a firewall 
driven exclusively by the regulatory function. Stakeholder engagement should be used in the 
planning and redesign processes, and these stakeholders must include the state laboratory 
partners. 
The Subcommittee is concerned about the level of connectivity within the network and the 
ability of state laboratories to participate effectively in the FERN network, including the larger, 
better-funded laboratories. If the larger more well-supported FERN laboratories are struggling 
in these functional capacities, where can we expect many of the other, smaller, and less-well-
supported laboratories to be? The Subcommittee’s sense is that that they are struggling on a 
more intense level. 
The Subcommittee believes that a dramatically new approach to data sharing is required. The 
need for a data infrastructure that is accessible and efficient is critical to the future value of the 
FERN network. The current data infrastructure “system” suffers from a combination of factors 
including its poor design, insufficient maintenance, and lack of perceived importance of what 
should be considered a vital food safety network that links federal and state partners in 
combatting foodborne illness. The need for modernization is serious. With the original FERN 
network design having omitted interoperability, all users miss opportunities to leverage data 
into good decision making and effective policy. The inability to capture analytical data from 
FERN laboratories is, in effect, an impediment to full utilization of the FERN-related cooperative 
agreements. 
Therefore, the Subcommittee concludes that it is important that FDA modernize its food 
safety information architecture to ensure safe and secure transmission of data, even while 
encouraging and facilitating efficient data sharing and collaboration across the entire 
network of food safety regulatory laboratories. 
 6.3 Benefits and Limitations to Funding FERN 
Question 3: What are the realized benefits and limitations to these FERN Network, laboratory 
accreditation, and Laboratory Associations (e.g., APHL, AFDO, AAFCO) cooperative agreements, 
and how can we improve upon the current utilization of the results of these agreements?  
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The Subcommittee asserts that FDA’s commitment to provide future funding opportunities to 
FERN, such as the FERN network, accreditation and laboratory association cooperative 
agreements, will be required to sustain and ensure the realization of a fully integrated 
multilevel (i.e., federal, state, local, and tribal) food- and feed-testing laboratory network. The 
Subcommittee found the following realized benefits and limitations: 
FERN’s Realized Benefits 
 Increased expansion of diagnostic capacity through acquisition of specialized 
equipment, instrumentation and technology. 
 Increased capability through specialized training efforts. 
 Increased capability through recruitment of scientists/experts. 
 Increased food-testing capability through method extension and enhancement studies. 
 Increased implementation of standardized methods, procedures, protocols, and quality 
processes aligned to ISO/IEC 17025:2005 improves overall network efficiency and 
testing precision. 
FERN’s Realized Limitations 
 Loss of FDA funding would be extremely detrimental to FERN testing capacity and 
capability. 
 Present funding is insufficient to replace/upgrade analytical instrumentation that has 
exceeded industry-defined life-span. 
 When funding is available, the ability to procure equipment easily and in a timely 
manner remains an administrative challenge. 
 The expectation to accommodate unanticipated two- to three-fold increases in testing 
(sample) volume without a corresponding budget increase for supplies, reagents, and 
labor costs caused an undue financial burden on participating laboratories. 
The Subcommittee’s review of the latest-available laboratory progress reports revealed that 
FDA-ORA’s oversight of CAP grantees was effective, as reflected by prior and current 
achievements and progress to date. However, the Subcommittee also determined that current 
funding levels can be insufficient to meet a number of critical operational expectations such as 
accommodating increased volumes of incoming sample testing; negotiating cost-effective 
service contracts; acquisitioning highly sophisticated diagnostic instrumentation; upgrading IT 
support/resources, including data sharing; and recruiting and retaining specialized and trained 
laboratory personnel. Generally, FERN CAP laboratories are expected to do more each year but 
on a flat budget; in some cases the incoming volume of food-/feed-testing samples has tripled 
(e.g., Richmond laboratory) due to FDA’s large-scale surveillance assignments and USDA-FSIS 
capacity testing, and doing quality and timely analysis on the ever-increasing number of 
samples thus is not sustainable. 
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Complicating the sample-volume issue is the inability for long-term planning for analyses by the 
CAP laboratories due to the inability of the FDA to provide consistent numbers of surveillance 
samples into the FERN CAP laboratories. The CAP laboratories were prepared to participate in 
FDA’s large-scale surveillance assignments, but these assignments were abruptly cancelled after 
one year. While this can relieve the financial burden imposed by increased sample volume, it 
prevents appropriate planning for reagents, equipment and personnel. Recognizing the 
unpredictable nature of food emergencies, there needs to be better coordination across the 
agencies to ensure proper planning to address the uneven workload and achieve efficient 
resource use. 
Meanwhile, loss of funding would greatly impact the overall capacity of FERN laboratories. 
Short-term impacts of funding reduction would include a negative impact on FERN’s ability to 
recruit and retain the highly trained scientists who are crucial for effectively using rapidly 
advancing diagnostic methodologies. Such a funding loss also would have an adverse short-
term impact on recruiting and retaining technicians with requisite high-level technical skills 
necessary to effectively and safely use complex instrumentation. For example, FERN support 
accounts for about one-third of overall funding at the Richmond, Va., laboratory, so, if funding 
were reduced, the chemical program could not be sustained. Long-term impacts of funding 
reductions would include a negative impact on the U.S. government’s ability to enhance and 
sustain the necessary FDA/FERN assets for proactive food-supply threat surveillance, as well as 
rapid detection and identification of large-scale food contamination (intentional or accidental). 
Among many findings related to FERN funding, the Subcommittee determined that a 
foundational level of support that would allow the development of core competencies across 
laboratories would be an excellent model, especially if it included a tiered system to support 
the development of enhanced laboratory capacity and advanced capabilities. Should such a 
system be established, it would be ideal if it could be expanded to allow the creation of 
regional/national centers, which could be the top tier of the network and thus house the top-
of-the-line (i.e., most sophisticated and expensive) instrumentation. The tiered organization 
would help avoid any tendency of a network of individual laboratories from collectively 
acquiring redundant expensive technical assets/resources. 
Therefore, the Subcommittee concludes that FDA’s commitment to provide future funding 
opportunities to FERN will be required to sustain and ensure the realization of a fully 
integrated multilevel (federal, state, local, tribal) food-testing laboratory network. Such 
future funding increases should be to increase the depth and breadth of the program, 
meaning both further increases to the capacity of existing laboratories as well as expanding 
the numbers of laboratories receiving FERN support. This is an investment that will save 
money in terms of reduced public health costs as well as costs to industry. 
6.4 Public Health Impact 
Question 4: How impactful to public health has this building of an integrated laboratory network 
and promotion of our state laboratories been to date? Explore case studies.  
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The FERN cooperative agreements have had a multifaceted impact on public health. FDA’s 
ability, through the FERN, to respond to an attack on the nation’s food supply, as defined and 
mandated by U.S. presidential directives, is greatly facilitated by the funding of the cooperative 
agreement laboratories. These CAP laboratories prepare to react to large-scale intentional food 
emergencies, to detect, respond to, and assist in recovery from such events. FERN is involved in 
surveillance assignments to detect related issues. Such assignments can be associated with 
large political events, responses to potential threats, or smaller, more-specific proactive 
surveillance of a particular geographic area or food product. 
The FERN CAP laboratories have also utilized their abilities to respond to large-scale 
unintentional food events and have been involved in every large food event in the United 
States since 2006. FERN responses have included the development and validation of rapid 
testing methods specific to the requirements of the specific event, providing scarce reagents 
and/or standards for testing, and testing capacity. For example, FERN provided rapid 
methodologies, reagents, and capacity for the 2006 E coli 0157:H7 outbreak associated with 
fresh spinach. FERN was also involved in responding to both melamine contaminations (2007 in 
pet foods and 2008/2009 in milk and proteins), the Deepwater Horizon oil spill of 2010, and the 
Fukushima Japanese nuclear reactor event of 2011. In these cases, FERN reduced FDA’s 
reaction time by working with FDA to provide improved rapid methods and the analytical 
capacity and capability to define the scope of the emergency and quickly recover from the 
event. The ability of FDA and FERN to promote a rapid recovery also has economic benefits; for 
example, the development of rapid testing methods and testing capacity by FDA and FERN 
facilitated the reopening of the Gulf waters to commercial fishing after the oil spill in 2010. 
Federal funding of FERN, including USDA-FSIS cooperative agreements (FY15 cost of $3.9 
million) and FDA cooperative agreements (FY15 cost of $10.1 million), resulted in the following 
outcomes: 
FDA and USDA-FSIS 
 Nine proficiency testing events were conducted. More than 240 laboratories 
participated and analyzed samples (e.g., ground pork, dried protein concentrate, 
mashed potatoes, dog food, apple juice, cheese, and acidified water) for a variety of 
analytes. 
 Annual check sample for the FERN Biosafety Level 3 High Risk Unknown Agent Screening 
Procedure for Food was provided to 15 FERN laboratories. 
 Multi-laboratory validations were performed on five newly developed methods, 
including: 
o A qualitative screening method for identification of 45 poisons/toxins, and 
o A Salmonella rapid screening method. 
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 Five new Food Defense methods for seven different analytes were evaluated, validated, 
and approved by the FERN Methods Coordination Committee and added to the 
repository of FERN methods. 
FDA 
 Nine training courses provided to more than 150 FERN laboratorians, including: 
o Select Agent training courses, 
o Rapid methodologies training courses including real-time polymerase chain 
reaction (PCR) methods, and 
o Radiological training courses. 
 Continued funding of the FERN Storeroom, providing reagents, supplies and standards 
to FERN laboratories. These reagents/supplies are typically difficult to obtain on an 
individual laboratory basis or are kept in bulk in the Storeroom for emergency response. 
An example of such reagents is the Clostridium botulinum toxin detection kits used by 
both FERN and FDA regulatory laboratories. 
USDA-FSIS 
 Targeted surveillance of USDA-regulated commodities (e.g., ready-to-eat [RTE] and raw 
meat and poultry products) at retail via FERN CAP partner laboratories was conducted. 
Eleven states tested 793 samples for chemical compounds (toxins, poisons, and heavy 
metals), eight states tested 616 microbial samples for selected agents in FSIS products 
found at retail locations within their jurisdictions. 
 Six laboratories participated in an exercise testing samples for a variety of chemical 
compounds where the specific contaminant was unknown. 
 Eight training courses in food testing and food defense methods were completed. 
Eighty-five laboratory personnel from state and local food testing laboratories attended 
courses covering microbiology and chemistry techniques for food analysis. 
o One online course of six modules covering a specific FERN toxin screening 
method was produced and hosted on the FERN website and has been used by an 
additional 75 laboratory personnel. 
o Radiochemistry training for the detection of a specific radionuclide was provided 
to three laboratories with a focus on a streamlined method with reduced testing 
time. 
FERN has also facilitated the coordination and sharing of expertise and essential resources, such 
as technical capabilities and analytical instrumentation among the partner laboratories. These 
resources can be applied not just at a federal and national level, but brought to bear on local 
and state food events. A particular benefit of FERN is its ability to facilitate access within the 
network to the various specialized instrumentation and analytical capabilities (i.e., radiological 
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toxicological, microbiological, and chemical analyses) that are distributed unevenly across 
FERN’s geographically dispersed laboratories. An anecdotal example is portrayed in this 
personal communication from a PhD analytical chemist at a FERN chemistry CAP laboratory: 
“We are an agriculture lab in small state; our FDA equipment has exponentially 
increased our capability and capacity. Right now, over 75% of the equipment in my 
laboratory is from FDA FERN CAP. In state fiscal year 2015, we processed in excess of 
3,000 samples, which included federal, state, and municipal samples, as well as 
samples from research projects on food safety (nanomaterial exposure) and 
pollinator decline. The matrices include food, soil/sediment, water, and diverse 
consumer products. Over 80% of those 3,000 samples involved direct use of our FDA 
equipment (LC-MS, ICP-MS and GC-MS). Because of this capability and the staff 
expertise, much of which can be traced to FERN involvement and training, we have 
become the go-to lab in the state and the region. In short, FERN equipment and 
involvement has become a critical core component to our operations.”20 
This ability to coordinate and share resources has a positive impact on public health. For 
example, the proficiency testing, methods development, training and surveillance activities 
outlined above greatly improve the preparedness and responsiveness of federal, state, local, 
territorial and tribal government agencies to food emergencies which, in turn, reduces the 
impact of such events on public health. Further, the use of common methods and protocols 
increases the likelihood that a problem across the nation or a region will be detected and the 
extent of the problem can be assessed more quickly. 
It is important to note that FERN could have an even greater public health impact with further 
investments. For example, FERN was not designed to conduct proactive nation-wide 
surveillance of the food system. However, engaging FERN more proactively in food safety and 
foodborne illness surveillance efforts may improve our overall ability to detect, respond to, and 
mitigate future events. Similarly, implementing the recommendations of this report (e.g., 
improved data sharing) should also increase FERN’s public health impact. As cited in the next 
section, it is important that metrics that can measure the public health benefit of FERN be 
developed. 
Based on this review, the Subcommittee concludes that FERN has a significant public health 
impact, and it is vital to maintaining public health preparedness and response. While it is 
impossible to quantify the health and economic benefits to society from FERN, the examples 
given in above illustrate the magnitude and breadth of the public health problems that FERN 
addresses. Thus, it is important that FDA and USDA-FSIS continue investing in FERN and 
consider increasing their support. 
6.5 Appropriate Metrics 
Question 5: What would be appropriate metrics to measure the effectiveness of these 
                                                          
20 White JC, Vice Director & Chief Analytical Chemist, Connecticut Agricultural Experiment Station. 
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integration strategies in promoting a national integrated laboratory system?  
The Subcommittee asserts that measuring the effectiveness of both FERN and the national 
integrated laboratory system is critical for informing funding decisions as well as protecting 
public health. However, it is difficult to determine with great confidence that the current 
national network of food emergency response laboratories is sufficient and worth the tens of 
millions of dollars invested to date. Choosing metrics that more specifically assess the public 
health impact will permit cost-benefit analyses that can show the return on this investment 
(See examples of metrics in Appendix D). 
The effectiveness of a network of laboratories in many respects is built on the effectiveness of 
the individual laboratories that comprise the network. Laboratory quality systems require 
evidence of precision, proficiency, reproducibility, accuracy, and documentation. Laboratories 
rely on their systems both to ensure reliable results, as well as to investigate errors. 
Accreditation to the relevant ISO standard (in this instance, ISO/IEC 17025:2005) ensures that 
these quality systems are operating and that the laboratory can provide reliable results for 
those methods under the scope of accreditation. Laboratory systems depend on both internal 
and external audits to maintain all elements of accreditation. 
Network- or national-level metrics could be developed around the requirements used for 
individual laboratories under cooperative agreements. Metrics for consideration could include 
the ability to report equivalent test results throughout FERN. For example, results reported by 
FERN laboratory 'X' would have the identical value and/or meaning and an equivalent time-to-
results as results by FERN laboratory 'Y' in another part of country. Tools to assess this metric 
could include proficiency testing or exercises to simulate an emergency event. Network-wide 
standardization and uniformity of testing protocols/procedures, reagent manufacturing, quality 
control/calibration material under the umbrella of a comprehensive QMS, like ISO/IEC: 17025, 
could also be used as a measurable metric for accuracy and reproducibility of test results across 
FERN. 
Therefore, the Subcommittee concludes that metrics are important for understanding the 
impact of FERN. ISO accreditation is considered the gold standard and is an important metric 
but it is not the only performance metric that should be monitored. FDA and USDA-FSIS in 
collaboration with state and local laboratories should be charged with developing a broader 
range of metrics that more directly assess public health impacts, functionality of the network 
as a system, as well as other goals, such as efficiency. 
7. Subcommittee Recommendations 
The FERN review Subcommittee, in response to its charge from the Science Board, developed 
the following set of recommendations in relation to FERN: 
Recommendations 
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1. FERN consists of a group of diverse laboratories, and the focus on developing a basic level 
of capability/capacity across the network is a worthwhile goal that should be supported by 
the federal government. The baseline capabilities/capacities needed are not static and 
funding should be adapted to reflect these changing needs. 
2. Efforts to build and sustain capabilities/capacities across FERN need consistent, multi-year 
funding. FDA should consider additional sources of funding, including cost-sharing or 
matching requirements for grant programs and recipients, where appropriate and/or 
possible. 
3. While all laboratories should strive to improve capabilities, especially as some techniques 
become more routine, FDA should develop a plan for FERN that would consider the 
advantages of a tiered approach designed to avoid unnecessary duplication, for example, of 
expensive instrumentation across the network. Thus, while all laboratories should share a 
basic level of functionality, the advanced performance capabilities could be housed 
primarily or exclusively in regional/national facilities and/or centers with the training and 
equipment to specialize in certain analytical areas of importance to both the state and the 
FERN missions, to promote efficient use of existing expertise, equipment, and technical 
resources. 
4. FERN funding agencies (i.e., FDA/ORA, USDA-FSIS) should continue to improve their 
engagement to discuss areas of common interest and combine efforts to improve testing 
capacity and capability within and across networks. 
5. FDA should develop a technology-management plan to anticipate the eventual replacement 
of existing instrument platforms that employ newer and more advanced diagnostic 
methodologies. The plan should be developed in collaboration with the designated 
specialty laboratories and include: platform selection, acquisition, upgrades/enhancements, 
along with corresponding technical training for personnel. 
6. FDA should assume a holistic approach to addressing the IT and data-sharing needs of FERN 
partners. There is a strong public health need for an integrated information infrastructure 
that allows the seamless transmission of data in a secure environment that facilitates rapid 
analytics. Simply trying to fix the current system is unlikely to achieve this goal; a new 
system is needed. Such efforts must be guided by a comprehensive plan that is developed 
through stakeholder engagement (i.e., cooperative laboratories) to meet the needs of an 
integrated food and feed safety system. 
7. FERN leadership should develop clear objectives and adopt a set of metrics for both 
individual laboratories and the network, with appropriate targets and consensus as to what 
constitutes success and reflects the objectives. 
8. FDA, in collaboration with other federal agencies, should convene an annual conference for 
the food safety laboratory network to engage scientists in professional 
education/development activities and facilitate the sharing of information. 
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9. FERN should have the capacity to support professional travel to conferences and/or for 
training and development. 
10. FDA and its sister federal agencies (i.e., USDA-FSIS, CDC) should work with states on best 
practices for hiring and retaining scientists who are needed to perform this mission-critical 
work. Possible collaborators for initiating such efforts include the National Governor’s 
Association and/or National Conference on State Legislatures. These organizations may be 
able to assist with the identification and/or development of models that can be considered 
for adoption by states nationally. 
11. FDA should regularly communicate with all eligible laboratories to increase public health 
preparedness and participation in FERN training efforts. 
The Subcommittee advises that the recommendations of this report be accepted with the 
utmost urgency and that our specific recommendations be considered as a means of ensuring 
the maintenance of a safe and secure food system. The FERN network represents one of the 
best national investments in improving the responsiveness of our combined federal, state, local 
and territorial governments; the development of IFSS, and the prevention of foodborne 
disease.
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Appendix A: Subcommittee Charge 
Request for Proposal to the Science Board to Be Classified by the Advisory Committee 
Oversight and Management Staff 
The Office of Regulatory Affairs (ORA) is hereby requesting that the Science Board establish a 
new subcommittee to evaluate the current investments in: (1) the Food Emergency Response 
Network (FERN) cooperative agreement program, and (2) funding for state laboratories to 
achieve International Organization for Standardization (ISO) accreditation. 
Goal: Ascertain how ORA can advance and establish an effective integrated laboratory network 
among ORA, FDA Center, and state public health and food- and feed-testing laboratories. Key 
areas of integration would include methods harmonization; data sharing, data quality, and data 
reporting; appropriate technical capabilities including IT; the role of proficiency testing and 
accreditation; and performance metrics. 
Background: The mission of FERN is to integrate the nation’s multilevel food-testing 
laboratories to detect, identify, respond to, and recover from a bioterrorism act or public health 
emergency/outbreak involving the food supply. FERN, established in 2004 by Presidential 
Directive, provides multiple areas of support to member laboratories, including cooperative 
agreement funding. Currently, there are 170 laboratory members in FERN, and FDA currently 
funds, through cooperative agreements, 34 state laboratories: 14 state chemistry laboratories, 
15 microbiological laboratories, and 5 radiological laboratories. These laboratories provide 
increased capability and capacity for laboratory sample analyses of food products for the rapid 
detection and identification of large-scale food contaminations, intentional or accidental, and 
have provided these functions for the FDA in most of the large-scale national food events since 
their initial funding. 
FDA/ORA has also invested funds to enhance laboratory capacity/capability and to assist state 
laboratories in attaining laboratory accreditation to recognized international standards (ISO/IEC 
17025:2005). These selected state laboratories are members of FERN and the states are 
enrolled in the FDA’s Manufactured Food Regulatory Program Standards (MFRPS), a set of 
standards developed by the FDA and selected state program managers that can be used by the 
states as a guide for continuous improvement for state food manufacturing programs. MFRPS 
Standard #10 addresses state laboratory services and their quality management systems. Many 
of the states funded to attain laboratory accreditation also participate in the Food Protection 
Rapid Response Teams, a program created to address the need for improved and integrated 
rapid responses to food and feed emergencies. 
FDA/ORA also funds a cooperative agreement with the Association of Public Health 
Laboratories (APHL), the Association of Food and Drug Officials (AFDO), and the Association of 
Animal Feed Control Officials (AAFCO) to further regulatory laboratory integration. This 
agreement seeks to facilitate long-term improvements to the national food and animal feed 
safety system by strengthening multi-disciplinary laboratory collaboration and equivalency, 
advance laboratory accreditation, and build an integrated laboratory community of state, local, 
and federal regulatory laboratories. 
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Scope of Work: The scope of work for this Subcommittee would include the evaluation of these 
three existing funding agreements and how these agreements or other approaches can best be 
utilized to build an integrated laboratory network among public health food- and feed-testing 
laboratories. Specifically, how can the Agency continue to build a sustainable integrated 
laboratory network that meets the public health and regulatory needs under an integrated 
national food safety system? Also, the technical areas of data sharing, proficiency testing, 
method harmonization, quality and reporting of analytical results would be assessed so as to 
provide recommendations to facilitate the rapid and efficient interchange of laboratory results 
in an integrated laboratory network. 
Questions for the Board 
1) How can we further promote and build an integrated laboratory network among the 
food regulatory laboratories of ORA, FDA Centers, USDA’s FSIS, and state health 
departments as part of developing a stronger system of mutual reliance in the food and 
feed program? 
2) What are the appropriate scientific, analytical, and technical capabilities required to 
facilitate the sharing of laboratory data between public health and regulatory agencies 
in a timely and efficient manner to enhance consumer protection? 
3) What are the realized benefits and limitations to these FERN Network, laboratory 
accreditation, and Laboratory Associations (e.g., APHL, AFDO, AAFCO) cooperative 
agreements, and how can we improve upon the current utilization of the results of 
these agreements? 
4) How impactful to public health has this building of an integrated laboratory network and 
promotion of our state laboratories been to date? Explore case studies. 
6) What would be appropriate metrics to measure the effectiveness of these integration 
strategies in promoting a national integrated laboratory system? 
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Appendix B: Schedule of Interviews with and Presentations to the 
Subcommittee 
October 9, 2015, presentation: 
APHL/AFDO 
Shari Shea 
Ron Klein 
Nancy Thiex 
Yvonne Salfinger 
 
October 23, 2015, presentation: 
USDA/FERN 
Randy Layton 
Ron Blakely 
 
November 17, 2015, presentation: 
FDA/ORA Office of Partnerships presentation on cooperative agreements 
Erin Woodom-Coleman (FDA) 
FDA FERN Overview 
Don Burr (FDA) 
 
November 30, 2015, presentation: 
FDA eLEXNET Overview 
JeanPaul Mivoyel (FDA) 
Solomon Tadele (FDA) 
Rahsaan Tabb (FDA) 
 
January 11-12, 2016, site visit: 
Commonwealth of Virginia, Division of Consolidated Laboratory Services – Richmond 
Denise Toney – Director 
Angela Fritzinger – Deputy Director 
Ed Shaw 
Chris Waggener 
Shane Wyatt 
 
February 24, 2016, interview: 
Maria Ishida, New York Dept. of Agriculture 
Andrew Cannons, Florida Dept. of Health 
 
March 2, 2016, interview: 
Michael Hydock (Pennsylvania Dept. of Agriculture) 
Robyn Atkinson (Utah – Public Health Lab) 
Phil Zillinger (Indiana State Dept. of Health) 
Judy Lovchik (Indiana State Dept. of Health) 
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Appendix C: Questions for Laboratory Site Visits 
The FDA Science Board Subcommittee on the Food Emergency Response Laboratory Network 
(FERN) has been charged with ascertaining how FDA’s Office of Regulatory Affairs (ORA) can 
advance and establish an effective integrated laboratory network among ORA, USDA-FSIS, FDA 
Centers, and state public health and food- and feed-testing laboratories. The deliverable for the 
Subcommittee is an evaluation/recommendations report that addresses the five objectives 
outlined below. For each objective, the Subcommittee identified a series of questions to be 
asked of laboratory staff during the site visits. 
Objective 1. Evaluate existing cooperative agreements with FSIS, APHL, AFDO, and AAFCO to 
further regulatory laboratory integration. Questions to address: 
1. Describe the funding sources you receive for regulatory laboratory activities. How much of 
what you do is funded by the Federal versus the State governments? 
2. Describe your relationships/cooperative agreements with FSIS, APHL, AFDO, and AAFCO. 
3. Does each agreement have a distinct ‘scope or task’? Or, do they overlap? 
4. Can you describe the specific activities for each of the funding streams? 
5. Can you describe some of the benefits since receiving this funding? Specifically, has the 
funding assisted you in expanding the scientific capacity of your operation? If so, how? 
6. What are the remaining areas needing improvement? 
7. Describe your experience and status with your laboratory accreditation process? 
8. Do you have recommendations to improve the grant/funding/procurement process? 
9. Do you have any suggestions to maximize the use of funds? 
10. What services, activities or initiatives would be impacted if funding were no longer 
available? 
11. Do you feel your experience/perspective is representative of all laboratories in the 
network? If not, how do you think it differs? 
 
Objective 2. Identify how the Agency can continue to build a sustainable integrated laboratory 
network that meets the public health and regulatory needs under an integrated national food 
safety system. Questions to address: 
1. Can you describe the network’s configuration and where this laboratory fits in? 
2. What are your thoughts regarding strategies to ‘sustain’ the network? 
3. How has public health benefited since the creation of the integrated laboratory network? 
4. How does the integrated laboratory network extend/expand the Agency's scientific 
capacity? 
5. What could the Agency be doing to strengthen scientific capacity across the network? 
 
Objective 3. Assess technical areas of data sharing, proficiency testing, method harmonization, 
quality and reporting of analytical results. Questions to address: 
1. How comfortable are the laboratory staff with the equipment they have? 
2. Can the proficiency testing program be improved? 
3. Has method harmonization impacted competency assessment of testing personnel? 
4. What is the quality of and consistency of reporting of analytical results across the network? 
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5. Are the network activities improving these capabilities? Do you have any thoughts about 
how to further improve them? 
 
Objective 4. Provide recommendations to facilitate the rapid and efficient interchange of 
laboratory results in an integrated laboratory network. Questions to address: 
1. What’s the current status of data sharing between FERN laboratories? 
2. What’s the current status of data sharing between FERN laboratories and FDA? 
3. What are the obstacles? 
4. Do you have recommendations for improving the exchange of laboratory results? 
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Appendix D: Examples of Metrics Used by FERN and Various Other Laboratory 
Organizations 
 
FDA FERN Cooperative Agreement Metrics 
1) CAP program metrics that are required by Cooperative Agreement Program guidance (2 
Code of Federal Regulations Part200 [2 CFR 200]): 
a. Quarterly reports including project information and budget information 
b. Final reports 
c. Monthly calls with project officers 
2) Equipment: 
a. Operational status of equipment loaned under the cooperative agreement 
b. Are service contracts maintained on all equipment loaned under the cooperative 
agreement? 
c. Are instruments operational greater than or equal to 90 % of the time? 
d. Reporting use/impact of equipment on routine laboratory operations (non-FERN-
directed activities) including: 
i. Improvement of capacity/throughput for normal laboratory sample analysis 
ii. Impact of any expanded capability resulting from provided instrumentation 
iii. Use of equipment to support routine state laboratory sample analysis and/or 
emergency outbreak sample analysis 
3) Participation by CAP laboratories in Proficiency Tests (PT) and check sample programs 
a. Laboratories report participation and pass/fail results for proficiency tests that they 
participated in during the reporting period 
i. PT sample sources: FERN, AOAC, other FDA (non-FERN), LRN, etc. 
ii. At this time, there is no minimum requirement for numbers of PTs expected to 
be performed during each reporting period 
4) Cooperative Agreement-Funded Project Accomplishments 
a. Report work/outcomes of any method development or matrix extension projects 
conducted under the award and anticipated impact of this work, including 
submissions of methods for consideration to become official FERN methods that are 
available to all FERN laboratories 
b. Report any state-initiated sampling programs conducted and funded through the 
award, including specific sample information: 
i. Numbers of samples analyzed 
ii. Products analyzed 
iii. Methods used 
iv. Results 
v. Provide full analytical worksheet packages as requested 
vi. Report any state or FDA regulatory action based on results from these state-
initiated surveillance sampling programs 
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5) FDA Directed Sampling: 
a. Report numbers of samples analyzed and results of any FDA directed or provided 
samples 
b. Provide official analytical worksheet data packages to be evaluated for potential FDA 
regulatory action based on sample results 
c. Track percentages of worksheets that meet FDA Center SME technical review 
approval requirements to support regulatory action 
d. Document any possible FDA regulatory action based on state data reports 
e. Document any issues with data worksheets that may prevent FDA use of that data to 
ensure issues are addressed and corrected for future data submissions 
6) Responsiveness: 
a. What is the measured response time of the CAP laboratory to activations or 
requests? 
b. Percentage of conference call/meetings attended by CAP laboratory during the 
reporting period 
c. Did CAP laboratory notify the FERN National Program Office (NPO) if capability or 
capacity was down for a significant period of time due to vacancies or equipment 
malfunctions? 
7) Outreach: 
a. CAP laboratories assisting non-funded FERN laboratories with training, sample 
analysis, proficiency test preparation, etc. 
b. Participation in activities supporting state Rapid Response Team programs 
c. Participation in Partnership for Food Protection (PFP) activities: 
i. Mutual Reliance Programs 
ii. Working groups 
d. Participation in FSMA implementation support activities 
e. List of publications resulting from FERN supported work 
f. List of meeting presentations resulting from FERN supported work 
 
DRAFT FSIS Metrics for FERN CAP Projects 
Since the CAP laboratories work mostly on individually proposed projects, the most common 
metric used for an individual laboratory in the FSIS CAP program is “completed”/“not 
completed.” 
Selected measures of laboratory’s acceptable progress in the program: 
1) Was the proposed project completed? Was project result published, presented, 
submitted as validated method to FERN, FDA, or USDA-FSIS? 
2) Did the laboratory increase in capacity or capability and is this reflecting the Laboratory 
Database (LabDIR) information on the FERN website (www.fernlab.org)? Example: 
Laboratory A increased in capability by verifying it could test for ricin in foods. This 
would be reflected in the LabDIR as a new capability. 
3) Participation by CAP laboratories in the PT and check sample programs. 
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4) Participation by CAP laboratories in the training courses. The numbers of students a 
state laboratory has sent to training courses might speak to their increases in 
capacity/capability as well. 
5) CAP program metrics that are required by Cooperative Agreement Program guidance (2 
CFR 200): 
a. Quarterly reports, including project information and budget information 
b. Final reports 
c. Monthly calls with project officers 
6) Completion of surveillance samples for food defense analytes. This metric is new for this 
year for USDA-FSIS. The goal is at least 250 samples for each USDA-FSIS CAP laboratory. 
This metric will be a pass/fail or incomplete “grading,” until it is determined that it 
should be measured differently. 
7) Capability and Capacity Exercise. USDA-FSIS CAP laboratories have participated in an 
exercise to demonstrate either their capacity or capability — as recorded in the LabDIR 
— through a functional exercise in which laboratories analyze samples supplied by 
USDA-FSIS. In the future, the USDA-FSIS CAP program could track time to reporting, 
number correct, number completed, and/or number of different analyses performed. 
 
Metrics that have been used for the FERN program as a whole: 
8) The FERN program instituted a tiering program that “grades” FERN participating 
laboratories based on the information in the LabDIR system. The tier system scores 
individual laboratories’ capabilities in the three testing disciplines (microbiology, 
chemistry, and radiochemistry), based on the information they submit to the LabDIR. 
Overall scores are compared and laboratories are divided into high, medium, and low 
categories in a system that only the FERN National Program Office can see. This system 
is useful for quick determination of laboratories’ capabilities in individual disciplines. 
9) The FERN program, in general, has tracked the number of training courses offered and 
the number of participants from individual laboratories, but no goal numbers have been 
established concerning participation by individual laboratories. The numbers of students 
a state laboratory, or the number of different laboratories that have sent participants to 
training courses might speak to the increase in capacity/capability of the network. The 
training program does try to fill all available seats in the offered courses, regardless of 
CAP status for the laboratories. 
10) Participation by FERN laboratories in the PT and check sample programs are tracked, but 
no goal numbers concerning participation in individual events have been established. 
The PT program does have its own metric of providing one PT per quarter, alternating 
between microbiology and chemistry. 
 
Metrics that have been considered, but not implemented, for the CAP program: 
1) Number of new matrices validated by a laboratory for a particular method. 
2) Completion of a method validation with submission of the data packet to the FERN 
Methods Coordination Committee. 
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3) Surveillance samples: 400 per year for tier-level-one laboratories, and 250 per year for 
tier-level-two laboratories. Analysis can be microbiology, chemistry, and/or 
radiochemistry. 
4) Include the ability of CAP laboratories to run USDA-FSIS Microbiology Laboratory 
Guidebook (MLG) and Chemistry Laboratory Guidebook (CLG) methods as part of the 
LabDIR information on the FERN website. This may increase capacity and capability of 
the laboratories as well as provide food safety surge capacity to USDA-FSIS. 
5) Include the status of CAP laboratories in terms of testing methods being designated 
either “equal to” or “same as” those of USDA-FSIS. 
 
Metrics considered but not implemented: 
1) Number of trained analysts for a specific method in a state laboratory (regardless of CAP 
status). The program did not have enough resources to train everyone at every 
laboratory. Also, the staff turn-over at state laboratories meant this could never be 
completed. Some state laboratories just do not participate in the training or are 
hindered by state policies from attending training. 
2) Correct results reported for PT samples, pass/fail criteria (regardless of CAP 
status).States that report incorrect PT results are contacted for follow up. However, no 
pass/fail or grading criteria is recording in the system. It was determined that if 
laboratories were graded, then laboratories would be less likely to participate, especially 
following a failing set. It has also been reported by the states that participating in a 
graded program for analytes outside of their accreditation scope would be a hindrance 
to their participation. We would much prefer they participate and practice an analysis 
that they do not run on a regular basis. 
3) Include the ability of CAP laboratories to run FSIS MLG and CLG methods as part of the 
LabDIR information in the FERN website. The may increase capacity and capability of the 
laboratories as well as provide food safety surge capacity to FSIS. 
 
Metrics no longer used/supported, mainly due to lack of resources: 
1) Participation of FERN laboratories, regardless of CAP status, in the Annual Training 
Conference with scientific sessions for specific disciplines as well as regional discussion 
groups 
2) Participation in regional meetings led by the National Program Office and regional 
coordinator to increase communication between laboratories on regional basis 
3) Participation in desktop exercises through regional coordination that demonstrated 
proficiency in responses to an event and FERN activation 
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Selected Laboratory Response Network (LRN) Metrics — CAPABILITY 12: Public 
Health Laboratory Testing* 
 
Public health laboratory testing is the ability to conduct rapid and conventional 
detection, characterization, confirmatory testing, data messaging and reporting, 
investigative support, and laboratory networking to address actual or potential 
exposure to all-hazards.260 Hazards include chemical, radiological, and biological 
agents in multiple matrices that may include clinical samples, food, and environmental 
samples (e.g., water, air, and soil).261 This capability supports routine surveillance, 
including pre-event262 and post-exposure activities.263 
 
This capability consists of the ability to perform the following functions: 
Function 1: Manage laboratory activities 
Function 2: Perform sample management 
Function 3: Conduct testing and analysis for routine and surge capacity 
Function 4: Support public health investigations 
Function 5: Report results 
 
Function 1: Manage laboratory activities 
Manage and coordinate communications and resource sharing with the jurisdiction’s network 
of human, food, veterinary, and environmental testing laboratory efforts in order to respond to 
chemical, biological, radiological, nuclear, explosive, and other public health threats. This 
function consists of the ability to perform the following task: 
 
Task 1: Exchange information and data with laboratories and laboratory networks 
within the jurisdiction. (For additional or supporting detail, see Capability 6: Information 
Sharing.) 
 
Performance Measure(s) (this is a partial list) 
This function is associated with the following CDC-defined performance measures: 
 
Measure 1: Time for sentinel clinical laboratories to acknowledge receipt of an urgent message 
from the CDC Public Health Emergency Preparedness (PHEP)-funded Laboratory 
Response Network biological (LRN-B) laboratory 
                                                          
* Note: This LRN material is necessarily incomplete due to length of the original document and includes only 
selected metrics. The complete document is available online (at 
https://www.cdc.gov/phpr/capabilities/capability12.pdf) and is thus in the public domain; however, it is used here 
with permission. The original superscript reference citation numbers are retained for reference purposes for the 
readers’ convenience, but the actual references are not listed because of space limitations in this report of the 
FERN Subcommittee. 
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 Start time: Time CDC PHEP-funded laboratory sends urgent message to first 
sentinel clinical laboratory 
 Intermediate stop time: Time at least 50% of sentinel clinical laboratories 
acknowledged receipt of urgent message 
 Intermediate stop time: Time at least 90% of sentinel clinical laboratories 
acknowledged receipt of urgent message 
 Stop time: Time last sentinel clinical laboratory acknowledged receipt of urgent 
message 
Planning (P) 
P1: (Priority) Written plans must include at a minimum the identification of laboratories 
and laboratory networks within the jurisdiction264,265 as well as procedures for 
interaction with the following laboratories and groups: 
o LRN-B reference laboratories within the jurisdiction 
 Support and ensure LRN-B reference laboratory communication with all LRN-B 
sentinel and all other LRN-B reference laboratories within the jurisdiction 
o Federal laboratory networks and member laboratories within the jurisdiction 
 e.g., the Food Emergency Response Network, National Animal Health 
Laboratory Network, and the Environmental Response Laboratory Network 
P2: (Priority) Written plans must include the following elements: 
o Documented procedures for contacting sentinel laboratories in the event of a 
public health incident 266 
P3: Written plans should include processes and protocols for continuity of operations 
(e.g., Continuity of Operations Plan or Annex) for chemical laboratory, radiological 
laboratory, biological laboratory and select agents consistent with federal guidelines, 
which are updated on an annual basis.267 Continuity of Operations should include not 
only the ability to conduct testing on unknown and unusual agents but also routine 
testing such as the assurance of newborn screening.268 Plans should address, but are 
not limited to the following elements: 
o Laboratory maintenance of redundant utilities supplies for testing and support 
areas for short-term duration (i.e., 72 hours) in case of localized infrastructure 
failure 
o Formal or informal agreements in place with other agencies to take over critical 
testing 
o Staff illness 
o Equipment failure 
Skills and Training (S) 
S1: Laboratory staff should be aware of current national policy and practice. Maintaining 
this understanding can be accomplished through sending one chemistry 
representative, one radiological representative, and one biological representative 
from the jurisdiction to the LRN national meeting. Also, it is recommended if possible, 
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but not required, that each LRN Laboratory Director also attend LRN national 
meetings. 
S2: At least one individual on staff should be capable of coordinating personnel safety and 
methods trainings, plans, and guidance, and outreach to sentinel and first responder 
communities throughout the jurisdiction. These staff should coordinate biological, 
chemical, and radiological activities. Depending on the jurisdiction, these positions 
may be filled by one or more individuals with the appropriate experience and training 
to perform the duties. 
Equipment and Technology (E) 
E1: Have or have access to a database of current contact information for identified LRN-B 
advanced sentinel laboratories, LRN-B reference laboratories, LRN-R laboratories (if 
program funds become available), and LRN-C laboratories in the jurisdiction, as well as 
laboratories both inside and outside the jurisdiction that work with the jurisdictional 
public health agency.269 
 
Function 2: Perform sample management 
Implement LRN-established protocols and procedures where available and applicable [and 
other mandatory protocols such as those for the International Air Transport Association (IATA) 
and the U.S. Department of Transportation (DOT)] for sample collection, handling, packaging, 
processing, transport, receipt, storage, retrieval, and disposal. 
 
Tasks 
This function consists of the ability to perform the following tasks: 
 
Task 1: Handle, package, and transport samples following established IATA/DOT and 
laboratory-specific protocols. 
Task 2: Maintain forensic chain-of-custody throughout the sample-management 
process. 
 
Performance Measure(s) 
This function is associated with the following CDC-defined performance measures: 
 
Measure 1: Percentage of LRN clinical specimens without any adverse quality assurance events 
received at the CDC PHEP-funded LRN-B laboratory for confirmation or rule-out 
testing from sentinel clinical laboratories 
o Numerator: Number of LRN clinical specimens without any adverse quality 
assurance events received at CDC-PHEP-funded laboratory for confirmation or 
rule-out testing from sentinel clinical laboratories 
o Denominator: Total number of LRN clinical specimens received at CDC PHEP-
funded laboratory for confirmation or rule-out testing from sentinel clinical 
laboratories 
Measure 2: Percentage of LRN non-clinical samples without any adverse quality assurance 
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events received at the CDC PHEP-funded LRN-B laboratory for confirmation or 
rule-out testing from first responders 
o Numerator: Number of LRN non-clinical samples without any adverse quality 
assurance events received at CDC PHEP-funded laboratory for confirmation or 
rule-out testing from first responders 
o Denominator: Total number of LRN non-clinical samples received at CDC PHEP-
funded laboratory for confirmation or rule-out testing from first responders 
Measure 3: Ability of the CDC PHEP-funded LRN-C laboratories to collect relevant samples for 
clinical chemical analysis, packaging, and shipping those samples 
o Sample Collection, Packing and Shipping Exercise Results (Pass/Did not pass) 
 
Resource Elements 
Note: Jurisdictions must have or have access to the resource elements designated as Priority. 
 
Planning 
P1: Written plans should include procedures and protocols for sample collection, triage, 
packaging, shipping, transport, handling, storage and disposal. Sample collection 
procedure should address 24/7 contact information and submission criteria. 
P2: Written plans should address transportation security and, at a minimum:270 
o LRN-B: Select Agent and Toxin Regulations 
o LRN-C: Chemical Hygiene Plan 
o LRN-R: Radiation Safety and Security Plan, if program funds become available 
P3: Written plans should include a protocol for chain of custody. Forensic chain of 
custody procedures must meet the minimum evidentiary control procedure 
requirements established by federal partners such as the Federal Bureau of 
Investigation (e.g., LRN, Integrated Consortium of Laboratory Network).271 
P4: Written plans should include procedures in place to maintain sampling and/or 
shipping supplies stock, or demonstrate ability to procure or have access to supplies 
24/7.272 
 
Skills and Training (this is a partial list, hence the non-continuous numbering) 
S1: (Priority) Laboratory staff responsible for sample management must maintain 
certification of laboratory personnel in a shipping and packaging program that meets 
national and state requirements (e.g., Sample Collection, Packing and Shipping; 
ShipPack). 
S4: Document training on practices for personnel safety while managing samples, with 
documentation updated a minimum of once per year, for laboratory personnel. 
S5: Maintain appropriate regulatory requirements, including the following elements: 
o A valid Select Agent Registration Number (LRN-B Advanced Reference 
laboratories only); Standard Reference laboratories are encouraged, but not 
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required, to maintain select agent registration to support broader public health 
response 
o A valid U.S. Department of Agriculture/Animal and Plant Health Inspection 
Service/Veterinary Services shipping permit (LRN-B laboratories only) 
o Nuclear Regulatory Commission or state licensing requirements (LRN-R 
laboratories only, if program funds become available) 
 
Function 3: Conduct testing and analysis for routine and surge capacity 
Perform, or coordinate with the applicable lead agency, testing of chemical, biological, 
radiological, nuclear, and explosive samples, utilizing CDC-established protocols and procedures 
(e.g., LRN), where available and applicable, to provide detection, characterization and 
confirmatory testing to identify public health incidents. This testing may include clinical, food, 
and environmental samples. 
 
Tasks 
This function consists of the ability to perform the following tasks: 
 
Task 1: Provide LRN-B reference-level testing in clinical, food, and environmental 
samples for both rapid and conventional methods. 
Task 2: Conduct chemical laboratory testing following LRN-C testing methods. 
Task 3: Conduct radiological and nuclear laboratory testing following LRN-R (if program 
funds become available) testing methods. 
 
Performance Measure(s) (this is a partial list) 
This function is associated with the following CDC-defined performance measures: 
 
Measure 1: Proportion of LRN-C proficiency tests (core methods) successfully passed by CDC 
PHEP-funded laboratories 
o Numerator: Number of LRN-C core methods successfully proficiency tested by 
the CDC PHEP-funded laboratory 
o Denominator: Total number of LRN-C core methods for which the CDC PHEP-
funded laboratory is qualified to test 
Resource Elements 
Note: Jurisdictions must have or have access to the resource elements designated as Priority. 
 
Planning 
P1: (Priority) Written plans should include the following considerations for surge 
capacity: 
o Options to optimize procedures based on regular and surge personnel, 
equipment, and facility resources for short-term (e.g., days) and long-term (e.g., 
weeks to months) response efforts 
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o Triage policies that address how the laboratory will manage surge testing, which 
may include: 
 Referral of samples to other jurisdictional laboratories 
 Prioritization of testing based upon sample type 
 Prioritization of testing based upon risk or threat assessment 
 Contingencies to assure newborn screening in a surge situation. Newborn 
screening can be assured by memoranda of agreement or contracts with 
commercial vendors273 
P2: (Priority) Written plans should include preventative maintenance contracts and 
service agreements in place for equipment and instruments utilized in LRN 
protocols, procedures, and methods at a minimum. Plans should also include 
protocols to ensure that equipment and instruments utilized in LRN protocols, 
procedures, and methods have been inspected and/or certified according to 
manufacturer’s specifications. 
P3: Written plans should include a process that provides guidance for referring 
suspicious samples (e.g., from sentinel laboratories or first responders) to an LRN 
reference laboratory. 
P4: Written plans should include considerations for supply accessibility, including 
identifying multiple vendors for critical commercially available reagents/supplies. 
P5: Written plans should include processes and procedures to operate at expanded 
laboratory capacity for surge events and incidents. 
 
Skills and Training 
S1: (Priority) Laboratories participating in radiological or nuclear testing must attain 
LRN-R (if program funds become available) Proficiency Testing Program Qualified 
status for all analysis methods transferred by LRN-R through the following: 
o Attending LRN–R training, if program funds become available 
o Completing the associated laboratory validation exercise, demonstrating 
performance and precision according to the minimum standards for each 
analytical method. 
S2: (Priority) LRN-B reference laboratories must attain competency for LRN-B testing 
methods by having the ability to test for all agents/sample types/tests listed in the 
high risk environmental sample testing algorithm posted on the secure LRN website. 
S3: (Priority) All LRN Laboratories (excluding LRN-B sentinel laboratories) must maintain 
the competency to pass LRN proficiency tests. 
S4: (Priority) Laboratories participating in chemical testing must attain LRN-C Proficiency 
Testing Program Qualified status, through the ability to perform the following: 
o Core LRN-C methods testing, for all Level 1 (surge capacity laboratories only) and 
Level 2 analysis methods transferred by CDC. Core LRN-C methods are identified 
on the LRN website and updated at least annually. 
o Validation and qualification of at least one new analysis method per year is 
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required. 
S5: Document LRN methods training, with documentation updated a minimum of once 
per year, for personnel that regularly perform LRN methods, as well as staff 
identified as surge-capacity personnel. Documentation should include training date 
and manner of delivery (e.g., formal training or “train the trainer”). Formal training: 
CDC courses and CD- or DVD-based courses, with completion verified by a formal 
demonstration. 
S6: If possible, (but not required) send one chemical, one radiological, and one 
biological laboratory representative to meetings focused on technical competencies. 
S7: Send at least one chemistry representative from each LRN-C Level 1 surge laboratory 
to participate in the bi-annual LRN-C Level 1 surge capacity meeting. 
S8: Document safety training, with documentation updated a minimum of once per 
year, for personnel that regularly perform LRN testing, as well as staff identified as 
surge-capacity personnel. Documentation should include training date and manner 
of delivery (e.g., formal training or “train the trainer”). Formal training: CDC courses 
and CD- or DVD-based courses, with completion verified by a formal demonstration. 
S9: Attain accreditation for LRN-C clinical testing, at a minimum, via an appropriate 
accreditation body [e.g., at a minimum, Clinical Laboratory Improvement 
Amendments (CLIA), or College of American pathologists (CAP)] 
S10: Attain accreditation for LRN-B clinical testing, at a minimum, via an appropriate 
accreditation body (e.g., at a minimum, CLIA or CAP) 
S11: Attain accreditation for LRN-R clinical testing, at a minimum, via an appropriate 
accreditation body, if program funds become available (e.g., at a minimum, CLIA or 
CAP) 
 
Equipment and Technology 
E1: Have or have access to a biosafety level 3 laboratory. 
E2: Laboratory owns and maintains at least one instrument each for rapid nucleic-acid 
detection and antigen-based detection and instruments are listed in the current 
equipment list (which is updated annually on the secure LRN website). 
E3: Level 2 laboratories own and maintain equipment for at least one instrument each 
for detection of LRN-C agents, that are listed in the current equipment list (which is 
updated annually on the secure LRN website), to demonstrate qualified status for 
the listed Level 1 (surge capacity laboratories only) and Level 2 methods. 
E4: Level 1 laboratories must obtain and maintain additional support equipment and 
supplies listed in each method. 
E5: LRN-R laboratories (if program funds become available) own and maintain 
equipment and maintain staff for at least one instrument each for detection of LRN-
R agents that are listed in the LRN-R Equipment List (which is updated annually on 
the secure LRN website). 
E6: Maintain inventory or reliable sources of testing material that includes CDC/LRN 
provided analyte-specific test kits, ancillary reagents, control strains, calibration 
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standards, and laboratory supplies required to run LRN analytical methods. 
E7: Have or have access to equipment necessary for performing LRN assays. 
 
Function 4: Support public health investigations 
Provide analytical and investigative support to epidemiologists, healthcare providers, law 
enforcement, environmental health, food safety, and poison control efforts to help determine 
cause and origin of, and definitively characterize, a public health incident. 
 
Tasks 
This function consists of the ability to perform the following tasks: 
 
Task 1: Establish and maintain the ability to provide analytical support for investigations 
with first responders and other health investigation community partners. (For 
additional or supporting detail, see Capability 13: Public Health Surveillance and 
Epidemiological Investigation.) 
Task 2: Provide investigative consultation and technical assistance to jurisdictional 
health departments, first responders, and other health investigation community 
partners regarding sample collection, management, and safety. (For additional or 
supporting detail, see Capability 13: Public Health Surveillance and 
Epidemiological Investigation.) 
 
Performance Measure(s) (this is a partial list) 
This function is associated with the following CDC-defined performance measures: 
 
Measure 1: Time to complete notification between CDC, on-call laboratorian, and on-call 
epidemiologist 
o Start time: Date and time that CDC Department of Emergency Operations 
official began notification of on-call laboratorian 
o Stop time: Date and time on-call epidemiologist (after receiving notification 
from on-call laboratorian) notifies CDC Department of Emergency Operations 
that notification drill is complete 
 
Resource Elements (this is a partial list) 
Note: Jurisdictions must have or have access to the resource elements designated as Priority. 
 
Planning (this is a partial list) 
P1: Written plans should include processes to coordinate activities, gain assistance from, 
and/or share data with the following group: 
o Epidemiologists who are at the interface between clinicians/hospitals, health 
departments, and the laboratory (For additional or supporting detail, see 
Capability 13: Public Health Surveillance and Epidemiological Investigation.) 
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o Veterinary diagnostic or food safety laboratories, if applicable, which serve 
animal populations and investigate food products (For additional or supporting 
detail, see Capability 13: Public Health Surveillance and Epidemiological 
Investigation.) 
Function 5: Report results 
Provide notification of laboratory results and send laboratory data to public health officials, 
healthcare providers, and other institutions, agencies, or persons as permitted by all applicable 
laws, rules, and regulations. 
 
Tasks (this is a partial list) 
This function consists of the ability to perform the following tasks: 
 
Task 1: Notify appropriate public health, public safety, and law enforcement officials 
(24/7) of presumptive and/or confirmed laboratory results from clinical, food, or 
environmental samples that involve a chemical, radiological, or biological threat 
agent. (For additional or supporting detail, see Capability 6: Information Sharing.) 
 
Performance Measure(s) 
At present this function is associated with the following CDC-defined performance measures: 
 
Measure 1: Time for CDC PHEP-funded laboratory to notify public health partners of 
significant276 laboratory results 
o Start time: Time CDC PHEP-funded laboratory obtains a significant laboratory 
result 
o Stop time: Time CDC PHEP-funded laboratory completes notification of public 
health partners of significant laboratory results (i.e., time when last public 
health partner was notified, if partners were not notified simultaneously) 
Resource Elements (this is a partial list) 
 
Planning 
P1: Written plans should include processes and protocols to ensure proper security and 
maintenance of records management system.277,278 (For additional or supporting detail, 
see Capability 6: Information Sharing.) 
P2: Written plans should include data-exchange processes, as permitted by all applicable 
laws, rules and regulations, with law enforcement, public safety, and other agencies 
with roles in responding to public health threats. These processes should address data 
security and inappropriate disclosure of information.279,280,281 (For additional or 
supporting detail, see Capability 6: Information Sharing.) 
P3: Written plans should include notification procedures that detail the process of reporting 
results that are suggestive of an outbreak or exposure to appropriate health 
investigation partners utilizing secure contact methods per the LRN-B, LRN-C, or LRN-R 
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(if program funds become available) Notification Policy and/or laboratory-specific 
policies.282 (For additional or supporting detail, see Capability 3: Emergency Operations 
Coordination and Capability 6: Information Sharing.) 
 
Equipment and Technology 
E1: (Priority) Each LRN laboratory will build or acquire and configure a jurisdictional 
Laboratory Information Management System (LIMS) with the ability to send testing data 
to CDC according to CDC-defined standards. (This will reduce the duplicate entry into 
multiple data exchange systems (i.e., having to put data into results messenger or other 
data exchange systems to be able to send to CDC, public health partners, and other 
submitters).283,284 
E2: Ensure at least one member of each laboratory area represented in the jurisdiction 
(LRN-B, LRN-C, LRN-R, if program funds become available) has a working digital 
certificate for access to electronic results-reporting systems. 
E3: Have or have access to at least one working computer for access to LRN and partner 
electronic reporting systems. 
E4: Have or have access to a mechanism (e.g., automated, electronic, or paper) for 
reporting results to LRN-B, LRN-C and LRN-R (if program funds become available), at a 
minimum, as appropriate.285 
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Associations (APHL, AFDO, AAFCO) Cooperative Agreement Draft Metrics (3/16/16) 
 
 
AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
Section # 1  
1 1.2- Online 
resource 
repository  
Grant Awareness of 
APHL 
Accreditation 
Resources 
website  
APHL Count from website 
Accreditation Resources 
(http://www.aphl.org/aphlprog
rams/food/laboratory-
accrediation/Pages/Accreditati
on-Resources.aspx) 
Yes With 
required 
reports to 
FDA 
Maintain or 
increase in # of 
views of 
accreditation 
resources website  
2 1.2- Online 
resource 
repository  
Grant Awareness of 
Accreditation 
Resource 
Repository 
APHL Count from website:  
Resources for Governmental 
Food and Animal Feed 
Laboratories  
Yes With 
required 
reports to 
FDA 
Maintain or 
increase in # of 
views of resource 
repository  
3 1.2- Online 
resource 
repository  
 
Grant Active work by 
the Associations 
to ensure 
updated 
resources  
APHL Count from website for 
Accreditation Resources and 
Resources for Governmental 
Food and Animal Feed 
Laboratories  
Yes With 
required 
reports to 
FDA  
# of new/updated 
documents added 
to resource 
webpage and 
repository  
annually. 
4 1.3- 
Accreditation 
discussion board  
Grant Use of 
Discussion 
Board 
APHL Count from Discussion Board 
SharePoint site:  Count # 
Topics/Unique threads 
Yes With 
required 
reports to 
FDA 
Maintain or 
increase in # of 
topics/ unique 
threads on APHL 
Discussion Board  
Section  #2 
5 2.1- Sampling 
and sample 
handling 
guidelines   
Grant Active work by 
the Associations 
to complete 
Guidance on 
Obtaining 
AAFCO Status of GOODSamples 
(completed) 
 
 
Yes Status 
report:Y03 
completion 
of 
GOODSamples 
completed. 
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
Defensible 
Samples  
(GOODSamples) 
GOODSam
ples 
6 2.1 Sampling 
and sample 
handling 
guidelines 
Grant Active work by 
the Associations 
to market 
GOODSamples 
AAFCO Marketing activities via APHL, 
AFDO, and AAFCO 
Yes Marketing 
activities 
with 
reports to 
FDA 
GOODSamples will 
be available and 
marketed through 
Association 
websites, 
newsletters, email 
and similarvenues. 
7 2.1- Sampling 
and sample 
handling 
awareness 
training  
Grant Providing 
awareness 
training on the 
principles of 
defensible 
sampling and 
Theory of 
Sampling (TOS) 
AAFCO Listing of seminars, dates and 
venues of awareness training on 
the principles of defensible 
sampling and Theory of 
Sampling (TOS) 
 
Yes With 
reports to 
FDA 
Laboratory 
managers and 
regulatory program 
staff will be aware 
of a shift in 
paradigm for 
sample collection, 
TOS and the GOOD 
Samples document. 
8 2.1- Sampling 
and sample 
handling   
Impact Adoption of 
sampling 
practices based 
upon 
GoodSamples 
 
survey Survey assessing use of 
GOODSamples and subsequent 
changes in practice  
(would be nice to have baseline 
practices, but can still assess 
changes/improvements in 
practice via self-reporting) 
No Annual 
 
 
 
 
  
GOODSamples 
practices are 
incorporated into 
regulatory 
programs which 
participated in 
Pilots.   
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
9 2.2- Web-based 
Subject Matter 
Expert (SME) 
registry  
Grant Convening and 
maintaining a 
web-based SME 
registry 
AFDO Counts from website- 
http://www.afdo.org/sme 
Yes 
 
Annual # registered SMEs 
annually by area of 
expertise; # of 
website hits on 
SME database. 
10 2.2- Web-based 
Subject Matter 
Expert (SME) 
registry  
Impact Value of SME 
registry 
 
 
 
AFDO 
research 
Survey of SMEs and 
laboratories/programs  
www.afdo.org/sme  
 (specifically Food Laboratory, 
Laboratory Accreditation, Pet 
Food Testing, Sampling 
categories) 
No 
 
 
 SME contacts 
resulting in 
assistance to a 
program or 
laboratory  
Section  #3 
 
11 
3.1- Marketing 
and outreach 
efforts around 
eLEXNET  
Grant  # of eLEXNET 
users running 
reports  
FDA FDA as part of CAP Yes   With 
required 
reports to 
FDA  
Increase in number 
of users running 
reports in eLEXNET 
12 3.3- Standard 
data elements.  
Identify existing 
vocabulary and 
data messaging 
standards and 
develop 
standards 
specific to food 
and feed-testing 
laboratory 
reporting 
Grant  Availability of a 
common set of 
data elements 
and messaging 
standards 
APHL, FDA APHL developed product  Yes  One time  Availability of a 
common set of data 
elements and 
messaging 
standards 
13 3.3- Standard 
data elements.  
Grant  # of laboratories 
adopting a 
APHL, FDA    Increase in the # of 
laboratories 
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
Identify existing 
vocabulary and 
data messaging 
standards and 
develop 
standards 
specific to food 
and feed-testing 
laboratory 
reporting 
common set of 
data elements 
and messaging 
standards 
 
adopting a 
common set of 
data elements and 
messaging 
standards 
14 Overall aim of 
data sharing 
Impact Action taken 
based on data in 
eLEXNET 
accredited 
scopes  
FDA and/or 
State 
Regulators 
(AFDO)  
Anecdotal information from FDA 
or AFDO members  
No  Action taken based 
on data in eLEXNET  
Section  #4  
15 4.5- Community 
building and 
networking  
Grant Active work by 
the Associations 
to ensure 
updated 
resources in 
Topical Index 
for Laws and 
Guidance 
AFDO Counts of #documents related 
to laboratory, laboratory 
accreditation, and sampling on 
Topical Index for Laws and 
Guidance from website- 
http://ti.afdo.org/ 
Yes Annual # of new/updated 
documents related 
to laboratory, 
laboratory 
accreditation, and 
sampling in Topical 
Index.  
16 4.5 Community 
building and 
networking  
 
Grant Awareness of 
Topical Index 
for Laws and 
Guidance 
AFDO Count of number of views of 
documents related to 
laboratory, laboratory 
accreditation and sampling on 
Topical Index for Laws and 
Guidance. 
Yes Annual Maintain or 
increase # of views 
of documents in 
the Topical Index 
for Laws and 
Guidance. 
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
17 4.6 Standardized 
training and 
competency for 
governmental 
food and feed 
testing 
personnel  
Grant Active work by 
the Associations 
to finalize the 
IFPTI 
competency-
based 
curriculum 
framework for 
Governmental 
Food and Feed 
Testing 
Laboratory 
Personnel 
AFDO Status of competency-based 
curriculum framework. 
 
Yes Annual Progress within 
agreed upon 
deliverables of 
subcontract with 
IFPTI; Ultimately, 
completed 
competency-based 
curriculum for 
Governmental 
Food and Feed 
Testing Personnel  
18 4.6 Standardized 
training and 
competency for 
governmental 
food and feed 
testing 
personnel  
Grant Providing 
awareness 
training of the  
Governmental 
Food and Feed 
Laboratory 
Curriculum  
AFDO Listing of seminars, dates, and 
venues of the Governmental 
Food and Feed Laboratry 
Curriculum Framework  
 
Yes With 
reports to 
FDA 
Laboratory 
managers will be 
aware of the 
Governmental 
Food and Feed 
Laboratory 
Curriculum 
Framework 
Training 
19 4.6- 
Standardized 
Training and 
competency for 
governmental 
food and feed 
testing 
personnel  
Impact  Adoption of the 
Governmental 
Food and Feed 
Laboratory 
Curriculum to 
create new 
training 
AFDO 
survey—
Future Data 
Collection 
Survey assessing use of 
Laboratory Curriculum and 
subsequent changes in practice  
(would be nice to have baseline 
practices, but can still assess 
changes/improvements in 
practice via self-reporting) 
 
 
No  Pending 
completion 
1. Creation of new 
training based on 
Governmental 
Food and Feed 
Laboratory 
Curriculum 
Framework; and 
2. State food and 
feed testing 
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
personnel are 
creating learning 
plans and basing 
staff training needs 
on Governmental 
Food and Feed 
Laboratory 
Curriculum.  
Section #5 
20 5 (5.1, 5.2, 5.3,  
5.4, 5.5)- 
Providing 
forums and 
improving 
communication 
and 
collaboration 
Grant Active work by 
the Associations 
to provide 
forums , 
committee 
meetings and 
member travel, 
etc.,for 
improved 
communication 
and 
collaboration 
APHL 
AAFCO 
AFDO 
Counts from each organization Yes With 
required 
reports to 
FDA   
Total # of 
events/committees 
and 
meetings/other 
events attended  
 
 
21 5 (5.1, 5.2, 5.3,  
5.4, 5.5)- 
Providing 
forums and 
improving 
communication 
and 
collaboration 
Impact Value of forums, 
committee 
meetings and 
member travel, 
etc., for 
improved 
communication 
and 
collaboration 
APHL 
AAFCO 
AFDO 
survey and 
success 
stories 
Anecdotal stories and/or blog 
posts, etc., following scientific 
meetings and conferences;  
survey to provide answer to 
question “Do you think that 
your communication with other 
laboratories/regulatory partners 
is improved since the CAP”? 
 
No  Communication 
and collaboration 
has improved since 
the CAP  
Section  #6  
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
22 6.2- Educational 
opportunities 
Grant Active work by 
the Associations 
to provide 
trainings to 
laboratories 
seeking/ 
maintaining 
accreditation 
APHL 
AAFCO 
AFDO 
Count from each organization 
 
Yes With 
required 
reports to 
FDA   
Increase in 
#trainings available  
 
23 6.2-  
Educational 
opportunities 
Grant Awareness of 
pre-recorded   
webinars 
APHL  Count # of registrations for 
webinars from website for 
individual webinars 
http://www.aphl.org/aphlprogr
ams/food/laboratory-
accrediation/Pages/Training-
Resources.aspx 
Yes With 
required 
reports to 
FDA   
Increase in # of 
registrations for 
webinars  
24 6.2- Educational 
opportunities 
Impact Evidence of 
applied learning 
(e.g., webinars/ 
seminars 
APHL  
training 
evaluations 
Follow-up survey to send to 
webinar registrants  
No Annual  Participants used/ 
applied webinar 
knowledge  
Section #7 
25 8.2- AAFCO 
Quality 
Assurance 
Quality Control 
Guidelines  
 
 
 
 
Grant 
 
 
 
 
 
 
Completion of 
Revised AAFCO 
Quality 
Assurance 
Quality Control 
Guidelines 
AAFCO Status of the AAFCO Quality 
Assurance Quality Control 
Guidelines (completed) 
 
 
 
 
 
Yes 
 
 
 
 
 
 
 
                                                 
One time 
in Y02 for 
completion 
of the 
AAFCO 
Quality 
Assurance 
Quality 
Control
Guidelines 
A revised version of 
AAFCO’s Quality 
Assurance Quality 
Control Guidelines 
completed.   
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
26 8.2- AAFCO 
Quality 
Assurance 
Quality Control 
Guidelines 
 
Grant Awareness of 
Revised AAFCO 
Quality 
Assurance 
Quality Control 
Guidelines 
AAFCO Provision of sales #s of 
publication; 
# of sales of the publication, list 
of marketing activities 
 
Yes  QA guidelines will 
be available and 
marketed through 
Associations 
website, emails and 
other such venues. 
27 8.2- AAFCO 
Quality 
Assurance 
Quality Control 
Guidelines  
Impact Implementation 
and Usage of 
Revised AAFCO 
Quality 
Assurance 
Quality Control 
Guidelines 
survey  Survey assessing use of revised 
guidelines and subsequent 
changes in practice  
(would be nice to have baseline 
practices, but can still assess 
changes/improvements in 
practice via self-reporting) 
No 
 
 
 
 
 
One time 
(Y04 or 
Y05)  
 
 
 
 
Change in QA/QC 
practices as a result 
of revised 
guidelines 
28 8.1- Proficiency 
testing program 
for laboratories 
testing animal 
feed  
Grant Active work by 
the Associations 
to achieve ISO 
17043 
Accreditation of 
PT program for 
animal feed  
AAFCO Status of accreditation to ISO 
17043 of the PT program for 
animal feed. 
Yes Annual 3rd party 
accreditation to ISO 
17043 received. 
29 8.1- Proficiency 
testing program 
for laboratories 
testing animal 
feed  
Grant Active work by 
the Associations 
to expand the 
PT programs for 
Feed 
Laboratories 
AAFCO Status of roll out of new 
programs 
 
 
Yes Annual New analyte(s) 
added annually. 
 
 
30 8.1- Proficiency 
testing program 
for laboratories 
testing animal 
feed 
Impact  AAFCO  No  PT Program is self-
supporting 
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
31 8.1- Proficiency 
testing program 
for laboratories 
testing animal 
feed  
Grant  Active work by 
the Associations 
to ensure use of 
PT programs by  
Feed 
Laboratories  
AAFCO Count from PT provider 
 
 
Yes Annual Maintain/increase 
in # of laboratories 
enrolling in and 
completing PT.  
 
 
 Overarching ISO measures 
32 FDA ISO 
Cooperative 
Agreement- 
Accreditation  
Impact Success of the  
FDA ISO 
Cooperative 
Agreement 
funding to help 
laboratories 
achieve or 
expand their 
scope of their 
accreditation 
FDA/survey 
by 
Assocations  
Specific stories through survey 
of laboratories- would obtain 
text/stories 
No   Specific successes 
outlining how the 
FDA ISO CoAg has 
helped with 
seeking, 
maintaining, 
expanding scope of 
accreditation  
33 FDA ISO 
Cooperative 
Agreement- 
Data acceptance 
(FDA)  
Impact Successful use 
of state 
laboratory data 
FDA/survey 
by 
Associations 
FDA to provide (Districts or OP?) 
or through survey.  
No  Increase in 
 # of labs 
submitting data 
packets 
 # of data 
packets being 
submitted 
 % of data 
packets being 
accepted for 
regulatory 
action by FDA  
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
34 FDA ISO 
Cooperative 
Agreement- 
Data acceptance 
(Intra/interstate)  
Impact Successful state-
specific 
regulatory 
action  
AFDO 
research 
Survey to AFDO’s members for 
specific stories of data used for 
state-specific regulatory action 
No   Use of state-
specific laboratory 
data for interstate/ 
intrastate for 
regulatory action 
35 FDA ISO 
Cooperative 
Agreement- 
Data acceptance 
Impact Successful use 
of state data for 
import alerts 
issued  
FDA/survey
by 
Associations 
Counts  
 
No    Increase in # of 
import alerts issued  
36 FDA ISO 
Cooperative 
Agreement- 
Accreditation  
Impact Success of the 
FDA 
Cooperative 
Agreement 
funding to help 
laboratories 
achieve or 
expand the 
scope of their 
accreditation? 
FDA/survey 
by 
Associations 
Counts 
 
No   Increase in # of 
laboratories that 
achieve or expand 
the scope of their 
ISO accreditation.  
37 Overall aim of 
working towards 
accreditation 
Impact Success of the 
FDA ISO 
Cooperative 
Agreement 
funding to help 
laboratories 
achieve or 
expand the 
scope of their 
accreditation 
FDA/survey 
by 
Associations 
Counts No  Annual  Increase in the # of 
laboratories with a 
quality manual.  
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
38 Overall aim of 
working towards 
accreditation 
Impact Success of the 
FDA ISO 
Cooperative 
Agreement 
funding to help 
laboratories 
achieve or 
expand the 
scope of their 
accreditation 
FDA/suvey 
by 
Associations 
Counts No  Annual  Increase in # of 
laboratories with a 
full-time Quality 
Mangaer  
39 Overall aim of 
working towards 
accreditation 
Impact Success of the 
FDA ISO 
Cooperative 
Agreement 
funding to help 
laboratories 
achieve or 
expand the 
scope of their 
accreditation 
FDA/suvey 
by 
Associations 
Counts No  Annual  Increase in # of 
laboratories who 
have chosen an 
Accrediting Body  
40 Overall aim of 
working towards 
accreditation 
Impact Success of the 
FDA ISO 
Cooperative 
Agreement 
funding to help 
laboratories 
achieve or 
expand the 
scope of their 
accreditation 
internal audits 
FDA /survey 
by 
Associations 
Counts No  Annual  Increase in # of 
laboratories who 
have conducted an 
internal audit.  
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AIM/activity 
being measured 
Grant or 
Impact? 
What is being 
measured?  
Who How will it be measured?  Already 
doable? 
Reporting 
Frequency  
Measure of 
Success  
41 Aim #1: Support 
programs 
Impact Value of 
Associations 
Cooperative 
Agreement on 
unfunded 
laboratories 
survey by 
Associations 
APHL as part of Yvonne 
Salfinger’s contract deliverables  
No  Annual  Increase in # of 
unfunded 
laboratories that 
achieved 
accreditation 
42 Aim #1:  Support 
programs 
Impact Value of the 
resources 
provided by the 
Associations to 
help 
laboratories 
achieve/enhanc
e accreditation 
Survey by 
Associations 
Survey value of different 
components (e.g., website, 
documents, meetings, webinars, 
SMEs) 
No Annual Specific success 
stories on how the 
accreditation 
resources offered 
by Associations 
helped laboratories 
achieve/enhance 
accreditation  
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